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Abstract 
Otitis media (OM) or middle ear inflammation is the most common pediatric disease 
and leads to significant morbidity. Although understanding of underlying disease 
mechanisms is hampered by complex pathophysiology it is clear that epithelial 
abnormalities underpin the disease. There is currently a lack of a well characterised 
in vitro model of the middle ear (ME) epithelium that replicates the complex cellular 
composition of the middle ear. Here we report the development of a novel in vitro 
model of mouse middle ear epithelial cells (mMECs) at air liquid interface (ALI) that 
recapitulates the characteristics of the native murine ME epithelium. We demonstrate 
that mMECs undergo differentiation into the varied cell populations seen within the 
native middle ear. Proteomic analysis confirmed that the cultures secrete a multitude 
of innate defence proteins from their apical surface. We could show that the mMECs 
supported the growth of the otopathogen, NTHi, suggesting that the model can be 
succesfully utilised to study host pathogen interactions in the middle ear. Overall, our 
mMEC culture system can help better understand the cell biology of the middle ear 
and improve our understanding of the pathophysiology of OM. The model also has 
the potential to serve as a platform for validation of treatments designed to reverse 
aspects of epithelial remodelling underpinning OM development. 
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Introduction: 
Otitis Media (OM) or inflammation of the middle ear is the most prevalent childhood 
disease, a leading cause of surgery in developed countries, and a significant reason 
for pediatric mortality in developing countries. Eighty percent of children suffer from 
at least one episode of OM by three years of age (Bakaletz 2010, Woodfield & 
Dugdale 2008).  
The middle ear epithelium is similar to the respiratory epithelium and is composed of 
ciliated cells, secretory cells, non secretory cells and basal cells. Secretory cells are 
responsible for the production of mucins and various anti-microbial proteins such as 
lactotransferrin, lysozyme, defensins and surfactants (Lim et al 2000, McGuire 
2002). The epithelium, along with its secretions, is involved in maintaining 
homeostasis and sterility within the middle ear cavity (MEC). Epithelial remodelling, 
characterised by mucociliary metaplasia and infiltration of the MEC with inflammatory 
cells, is a common feature of OM (Straetemans et al 2001).  
In most animals, the middle ear is a relatively inaccessible organ lined by a thin 
mucociliary epithelium and sampling of the mucosa is a terminal procedure. Human 
middle ear tissue can be acquired only during surgical procedures and this limits the 
amount of sample available for study of OM. Culturing of middle ear cells in vitro 
enables maximisation of the available material, allows the effect of modifying culture 
conditions to be studied more easily and also allows functional studies to be 
performed. Previously, attempts have been made to culture middle ear epithelial 
cells from a number of organisms including rats (Toyama et al 2004, Ueyama et al 
2001, Vanblitterswijk et al 1986), mice (Tsuchiya et al 2005),  chinchillas (Amesara 
et al 1992, Nakamura et al 1991), gerbils (Herman et al 1992, Portier et al 2005, 
Takeno 1990), rabbits (Schousboe et al 1995) and humans (Choi et al 2002, Chun et 
al 2002, Moon et al 2000). These studies have included organ and explant cultures, 
primary cell cultures and development of middle ear cell lines.  
However, there remains a lack of a robust in vitro middle ear epithelial model that 
differentiates into the different epithelial cell types of the middle ear and is free of 
fibroblast contamination. This has greatly restricted the ability to identify the function 
of different cell types and their products within the middle ear and limits our 
understanding of the pathophysiology of OM development. 
We report here the development of a novel in vitro primary model of the mouse 
middle ear epithelium using air liquid interface (ALI) culture and systematically 
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characterise the different cell types present in the middle ear. We also demonstrate, 
that this culture system can be utilised to study host pathogen interactions within the 
middle ear and thus has the potential to allow investigatation of the mechanisms of 
OM pathogenesis. 
 
 
Results: 
We established an air liquid interface (ALI) culture system to model the mouse 
middle ear epithelium in vitro (Fig. 1A). We performed a morphological analysis and 
systemactically characterised the various epithelial cell types expressed by our 
model in comparison to the native mouse middle ear epithelium.  
 
Cell culture characteristics  
The average number of epithelial cells isolated was 74,667±10,621 cells per MEC 
(n=12 batches). Primary culture of mMECs proceeded in two phases – a proliferative 
phase in submerged culture and a differentiation phase at air liquid interface (Fig. 
1B-H). mMECs were seeded at a density of 1x104 cells/ membrane and 3 days after 
seeding 16.8±2.6% adhered to the membrane and had started forming small 
epithelial islands (Fig. 1B). The attached cells began to elongate to establish contact 
with neighbouring cells and began to proliferate rapidly from day 5 to day 7 (Fig. 1C, 
D). Cells formed a confluent monolayer of flat, polygonal cells within 9 to 10 days in 
submerged culture (ALI Day 0) in the presence of Rho Kinase inhibitor, ROCKi (Fig. 
1E). The morphology of the cells became more complex when transferred to ALI. At 
ALI Day 3, cells started changing in size and shape (Fig. 1F) and by ALI Day 7 two 
distinct sub populations of cells could be observed, the majority of which were flat 
polygonal cells, intersected with clusters of slightly elevated, more compactly 
arranged cells (Fig. 1G). Around ALI Day 9, ciliary beating could be seen in these 
clusters under phase contrast microscope. ALI Day 14 cells 
(1.2x105cells/membrane) displayed a cobble-stone appearance with well-defined cell 
boundaries; and were a combination of flat polygonal cells and compactly clustered 
elevated cells with actively beating ciliated cells. (Fig. 1H, Movie S1). No cells with 
fibroblast-like morphology were seen in the mMEC ALI cultures. However, fibroblasts 
were isolated through differential adherence to plastic during the cell isolation 
process. (Fig. 1I).  
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Cell morphology  
Electron microscopy analysis during ALI culture revealed the development of a 
mucociliary epithelium (Fig. 2). At ALI Day 0 (undifferentiated cells), scanning 
electron microscopy showed uniformly flat, large cells with microvilli on the apical 
surfaces (Fig. 2A). At ALI Day14, the cells exhibited a dome shaped appearance 
(Fig. 2B), areas of flatter polygonal and secretory cells with microvilli on the apical 
surfaces and areas abundant in ciliated cells (Fig. 2C). The morphology of the ALI 
Day 14 mMEC cultures resembled the in vivo middle ear epithelium (Fig. 2D). 
Transmission electron microscopy revealed that ALI Day 14 cells were polarized with 
desmosomes on the baso-lateral surfaces suggesting the formation of tight junctions, 
another feature of epithelial cells (Fig. 2E). The formation of tight junctions was 
further confirmed by uniform expression of ZO-1 in the cell membrane (Fig. 2F)  
 
Expression of epithelial markers by mMEC cultures 
The expression of a selected panel of genes, known to be expressed by the middle 
ear epithelium and upper airways, was analysed by RT- PCR of RNA from the 
original mMECs before seeding and compared to ALI Days 0 and 14 cells. 
Fibroblasts isolated by differential adherence were used as a negative control for 
epithelial markers (Fig. 3A). Bpifa1 and Bpifb1 are secreted, putative innate immune 
molecules expressed in the upper airways. Bpifa1 was expressed strongly in the 
original and ALI Day 14 cells, but lower in the undifferentated ALI Day 0 cells. Bpifb1 
was detected only in the original cells, not in cultured cells. Tekt1 (a marker of 
ciliated cells) was detected at ALI Day 14. Analysis of Muc5ac and Muc5b 
expression, markers of goblet cells, suggested that Muc5ac was weakly expressed 
in  mMEC original cells but was not detectable in the cultured cells, whereas Muc5b 
was expressed more strongly in the original cells and maintained this expression to 
ALI Day 14. We also studied the mucosal innate immune genes Lactotransferrin, 
Surfactant protein D (Stfpd) and Regenerating islet-derived protein 3 gamma 
(Reg3ᵞ). Lactotransferrin and Reg3ᵞ were detected in the mMEC original cells and at 
ALI Days 0 and 14, whereas expression of Stfpd was seen in the cells during ALI 
differentiation. As expected, the expression of Keratin5, a marker of basal cells, was 
reduced as cells differentiated from ALI Day 0 to Day 14. The expression of these 
epithelial markers in the mMEC cultures indicates that the cells differentiate in 
culture from ALI Day 0 to ALI Day 14 and the pattern of expression in the 
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differentiated cells is in line with that seen in the  mMEC original cells isolated from 
the middle ear. The absence of Vimentin in ALI Day 14 cultures indicates that our 
mMEC cultures are devoid of fibroblast contamination. Oaz1 was used as a 
housekeeping gene for all RT-PCR experiments.  
 
MS analysis of the apical secretome of mMECs 
To complement our gene expression studies, we also performed a global proteomic 
analysis of apical ALI Day 14 secretions of mMEC cells by Orbitrap mass 
spectrometry (MS). Table 1 lists the most abundant secreted proteins identified 
classified according to their emPAI score. The most abundant secreted protein was 
Lactotransferrin, with Serotransferrin, Reg3ᵞ, Lipocalin2, Ceruloplasmin and Bpifa1 
also being found at high levels. Multiple anti-proteinase and proteinase proteins were 
also found in the secretions including members of the WFDC family, WFDC2, 
WFDC18 (EXPI) and SLPI (WFDC4), as well as multiple cathepsins.  We validated 
the secretion of Bpifa1, Lactotransferrin and Reg3ᵞ in the apical washes from the 
differentiating mMEC cells using western blotting (Fig. 3B,C). The full list of proteins 
identified is given in Table S1. 
 
Localisation of epithelial markers in mMEC cultures. 
We used immunofluorescence confocal (IFC) microscopy to study the localisation of 
epithelial markers in ALI Day 0 and ALI Day 14 cultures, in order confirm the 
differentiation process at the protein level. ALI Day 0 cultures showed abundant 
staining of P63 (basal cell marker), scanty staining of Bpifa1 (Fig. 4A) and no 
staining of FoxJ1 (ciliated cells) and Muc5B (goblet cells) (Fig. 4C). However by ALI 
Day 14, the cells had differentiated into multiple cell types. These stained strongly for 
Bpifa1, had reduced levels of p63 (Fig. 4B) and were populated with ciliated and 
goblet cells (Fig. 4D). Bpifa1 was localised the non ciliated population in 
differentiated mMECs, consistent with that seen in the in vivo middle ear epithelium 
(Fig. S1).  In keeping with proteomic and expression data, we also detected 
abundant cytosolic levels of Lactotransferrin and Reg3ᵞ in the ALI Day 14 cultures 
(Fig. 4E, F). Staining of nuclei with DAPI and Z-slice imaging using confocal 
microscopy also demonstrated that the cells formed a flat monolayer at ALI Day 0, 
but showed a more complex reorganisation by ALI Day14 with a combination of flat 
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and elevated cells showing 2 or 3 different layers, with nuclei further away from the 
base of the membrane (Fig. 4G, H).  
 
Relative abundance of secretory and ciliated cells 
As noted above, phase contrast microscopy and SEM of mMEC cultures 
demonstrated that the ALI Day 14 cultures were composed of distinct anatomical 
areas of flat polygonal cells and patches of more elevated pseudostratified cells (Fig. 
1H, Fig.  2B). To study this in more detail, we used IFC to determine the localisation 
of different epithelial markers within the two regions of cellular morphology. FoxJ1 
positive ciliated cells and Muc5B positive goblet cells, were restricted to the elevated 
pseudostratified cell clusters, whilst Bpifa1 was more commonly seen in the flatter 
cells, although some staining was seen in the elevated cells, especially near the 
periphery (Fig. 5). This was consistent with our observation that ciliated cells could 
be seen beating in the elevated clusters of cells under light microscopy. We also 
confirmed Bpifa1 and Muc5B positive cells were not ciliated (Fig. 5A, B). Again this 
alaysis confirmed the existence of elevated pseudostratified cells within the cultures 
(Fig. 5C,D). 
 
mMEC ALI cultures as an otopathogenic infection model 
Having established a novel mMEC culture model, we wanted to evaluate its utility as 
a model system for the study of host pathogen interactions in the middle ear. We 
infected differentiated ALI Day 14 cells with a GFP-tagged NTHI 375SR. IFC 
microscopy indicated that only a few cells were infected 24 hpi but by 48 hpi the 
infection rate had increased and the bacteria continued to spread laterally in culture 
infecting the majority of cells by 72 hpi (Fig. 6A-C). We confirmed this observation by 
quantifying the amount of green fluorescence using image analysis and observed 
that in every batch the amount of bacterial infection increased in a time dependent 
manner (Fig. 6E, Fig. S2).  
We also studied the expression of the pro-inflammatory chemokine Cxcl2/MIP2α 
during the progression of infection. Cxcl2 was significantly upregulated post infection 
at 24hpi (131 fold) and 48hpi (36 fold) compared to the 24hpi MOCK sample set as 
the reference (Fig. 6F). This data confirms that our mMEC model is capable of 
eliciting an inflammatory response. 
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Discussion: 
We have developed a novel in vitro model for the culture and differentiation of 
primary mouse middle ear epithelial cells (mMECs) cultured at an air liquid interface. 
The ALI system has previously been used to culture respiratory epithelial cells (TBE) 
from several species (Clarke et al 1992, Davidson et al 2000, Yamaya et al 1992, 
You et al 2002) and more recently, it has been applied to the culture of murine nasal 
epithelial cells (Woodworth et al 2007). The exposure of apical cell surfaces to air 
and the supply of nutrients from the basal compartment mimics the in vivo upper 
airway epithelium and promotes differentiation. As the middle ear epithelium can be 
considered to be an extension of the upper airways and exhibits physiological 
similarities to the upper respiratory tract, we reasoned that we could extend the use 
of the ALI system for the successful culture of primary mMECs. 
Our mMEC cultures can be used to study both proliferation and differentiation of 
middle ear cells. The medium used for the culture of mMECs was the same as that 
used for culture of mouse tracheal epithelial cells, mTECs (You et al 2002). The 
media supplements, epidermal growth factor, insulin, transferrin and cholora toxin 
enhance cell proliferation and ciliogeneisis whereas retinoic acid is important for 
differentiation of mucous cells (Lechner et al 1982, Wu et al 1997, You & Brody 
2013, You et al 2002). The addition of ROCKi to the culture medium has been shown 
to enhance basal cell proliferation in airway epithelial cultures (Horani et al 2013). 
Using ROCKi, we could maximise the number of transwell-cultures established from 
the limited number of cells isolated from the thin middle ear epithelium without 
altering differentiation (Fig. S3); an observation that has been made in both human 
and mouse airway cells (Butler et al 2016, Horani et al 2013) and thus reduce the 
number of animals required for each batch of cells cultured. mMECs grown at ALI 
differentiated into different cell types by ALI Day 14, a typical timescale used for the 
differentiation of murine respiratory epithelial cells (You et a 2002). We extended this 
culture period to ALI Day 18 without any morphological differences (data not shown); 
however further time points were not tested. 
An important and common problem identified in a number of previous attempts to 
grow middle ear epithelial cells was the contamination and overgrowth of fibroblasts 
in the cultures (Nakamura et al 1991, Tsuchiya et al 2005, Vanblitterswijk et al 1986). 
By adding a differential adherence step, in which fibroblasts adhere to plastic in 
preference to the epithelial cells, we were able to eliminate fibroblasts from our 
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mMEC cultures, generating a pure epithelial population, as shown by a lack of 
expression of the fibroblast marker, Vimentin, in ALI Day 14 cultures. 
The mMEC cultures model the native middle ear epithelium as the cells exhibit 
characteristic epithelial features such as a cobble-stoned morphology, formation of 
tight junctions, apical-basal polarised, presence of desmosomes and apical microvilli. 
The cultures contained a combination of single layers of flatter polygonal cells and 
clusters of pseudostratified, dome shaped, elevated cells, with some of these having 
beating cilia. The dome shaped appearance of cells can be attributed to an active ion 
transport mechanism (Chun et al 2002, Nakamura et al 1991).  
A major limitation of previous middle ear epithelial cultures has been the lack of 
differentiation into distinct epithelial cell types. The middle ear epithelium, like the 
upper airway epithelium, is composed of ciliated cells, basal cells, goblet cells and 
other secretory cells. Previous studies outlined difficulties in maintaining ciliated cells 
in culture (Nakamura et al 1991, Ueyama et al 2001). To our knowledge, the 
development of ciliated cells has only been described in one study of human middle 
ear cultures (Choi et al 2002), also grown at the ALI. Our cultures clearly show the 
presence of actively beating cilia and also stain for nuclear FoxJ1 protein. We found 
that the distribution of cilia in our cultures partially mimics that seen in the native 
middle ear epithelium by SEM (Fig. S4). Parts of the middle ear epithelium are 
populated with tracts of dense cilia, parts with interspersed ciliated and non-ciliated 
cells and some parts with a simple epithelium composed of flat non-ciliated 
polygonal cells. This distribution of cell types within the middle ear cavity is 
supported by previous studies (Lim 1979, Thompson & Tucker 2013) which show 
that the native epithelium of the hypotympanum and towards the opening of the ET is 
densely packed with cilitaed cells, whereas the mesotympanum contains ciliated 
islands amongst other non ciliated cells. The epitympnaum is composed primarily of 
of flat squamous cells which may also contribute to the secretory defence system. 
On this basis, we believe that our mMECs, which are a combination of flat non 
ciliated, secretory and ciliated cells closely model the morphology of the native 
middle ear epithelium.   
Mucins are products of goblet cells, unique to the mucosal epithelia, and are 
essential in the maintenance of mucosal innate defence. A number of attempts have 
been described to utilise the available middle ear models to study mucin gene 
expression at the transcriptional level (Kerschner et al 2010, Liu et al 2016, Moon et 
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al 2000, Tsuchiya et al 2005). However, these studies were limited by the lack of 
production and localisation of detectable amounts of mucins at the protein level. 
Goblet cells (as shown by MUC5B positivity) were seen in the elevated 
pseudostratified clusters of our ALI Day 14 mMEC cells in close association with 
ciliated cells. It has previously been shown that in the native middle ear epithelium 
the abundance of mucous secreting cells is in parallel to the distribution of ciliated 
cells, reiterating that our model mimics the in vivo middle ear epithelium (Lim et al 
1973). MUC5B is the predominant mucin in COM effusions (Preciado et al 2010). It 
has been shown to be indispensible for airway mucocilary clearance and 
maintainence of mucosal homeostasis and Muc5b-/- mice develop OM (Roy et al 
2014) Expression of MUC5B at proteomically detectable levels as demonstrated by 
IFC enables our model to be potentially utilised for further study of the role of mucins 
in the middle ear epithelium. Moreover, treating primary tracheal and bronchial 
epithelial cells grown at ALI with IL-13 has been shown to induce goblet cell 
hyperplasia(Atherton et al 2003, Kondo et al 2002). Our model provides a platform to 
study middle ear mucous hypersecretory phenotypes in vitro. The lack of MUC5AC 
or MUC5B in our MS analysis may be due of the loss of these high molecular weight 
glycoproteins during the sample processing and preparation. 
In addition to ciliated and goblet cells, our cultures also produce a range of other 
secretory cell products. Bpifa1 is the most widely studied member of the BPI fold 
(BPIF) containing family of putative host defence proteins (Bingle et al 2011) and we 
have previously shown it to be an abundant product of the murine upper respiratory 
tract and nasopharynx (Musa et al 2012). BPIFA1 was identified as a candidate for 
OM in a recent GWAS study (Rye et al 2012) and loss of the protein has been 
implicated in the development of OM in aged mice (Bartlett et al 2015). Bpifa1 was 
readily detectable in mMEC cultures and apical secretions from the cells. Bpifa1 was 
localised to non-ciliated cells in the cultures, which is consistent with studies from the 
respiratory tract (Barnes et al 2008, Kim et al 2006, Musa et al 2012).  Bpifb1, on the 
other hand, was detectable in the original cells, but not in the ALI Day 14 cultures 
and was absent from the list of proteins identified in the proteomic analysis 
performed using mass spectrometry. Bpifb1 protein is localised to goblet cells and 
minor glands associated with the Eustaschian tube (ET), but its expression is limited 
in the middle ear epithelium (data not shown). This observation suggests that our 
mMEC cultures model the middle ear epithelium rather than the ET epithelium.  
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Proteomic analysis by MS identified a number of secretory proteins in the apical 
washes from the cells. The most abundant proteins comprised a variety of secretory 
host defence proteins with anti-microbial roles, proteins involved in cellular 
proliferation, wound repair, stress response, compliment activity and maintenance of 
cellular homeostasis. It is notable that our MS data contains a number of proteins 
also identified in a proteomic analysis of ear exudates from Chronic OM patients 
such as Lactotransferrin, Bpifa1, Lipocalin, Lysozyme and various cathespins and 
complement proteins (Val et al 2016). Lactotransferrin was the most abundant 
protein identified in our study. It is an innate immune protein secreted by airway 
mucosal surfaces that has been shown to play a role in maintenance of middle ear 
immunity (Bernstei.Jm et al 1974, Lim et al 2000, Moon et al 2002). It prevents 
colonisation of mucosal surfaces by scavenging environmental iron, thus limiting its 
availability for bacterial growth. Human milk Lactotransferrin has been shown to 
attenuate the pathogenic potential of Haemophilus influenzae by proteolytically 
cleaving two important colonisation factors found on the bacterial surface 
(Hendrixson et al 2003) and the administration of Apolactoferrin has been shown to 
reduce bacterial counts in chinchilla middle ears with pneumococcal induced OM 
(Schachern et al 2010). Surfactant protein D was originally identified as a lung 
surfactant associated protein but is also expressed in the ME and the ET and has a 
suggested role in enhancing opsonisation and phagocytosis of bacteria (Lim et al 
2000, van Rozendaal et al 2001, Wright 1997). Reg3γ is C-type lectin produced by 
Paneth cells and secreted into the intestinal lumen with a suggested bactericidal 
activity against gram-positive bacteria by binding to peptidoglycan in the bacterial 
cell wall (Cash et al 2006). It has been shown to spatially regulate the separation of 
microbiota from the host small intestinal epithelium (Vaishnava et al 2011). Reg3γ-/- 
mice have an altered mucosal distribution and increased inflammatory response in 
the small intestine (Loonen et al 2014). Reg3γ has also been shown to be involved in 
pulmonary innate immunity as it is induced by Stat3 during methicillin resistant 
Staphalococcus aureus (MRSA) infection in lung and inhibits MRSA growth in vitro   
(Choi et al 2013). This is the first study reporting the expression of this protein in the 
ME and it is possible that Reg3γ performs a similar function in the middle ear.  
It was noticeable that the proteomic data unexpectedly contained many intracellular 
proteins. We also detected the presence of the membrane tethered mucins Muc1, 
Muc4 and Muc18. (Table S1). This can be reasoned to be the content of secreted 
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exosomes. Exosomes are small membrane bound units released by the fusion of 
endosomal micro vesicular bodies with the apical plasma membrane. They have 
been suggested to be involved in stimulating immune responses, modulating 
secretory activities and engaging in cell communication by packaging and delivering 
microRNAs to other cells (Keller et al 2006, Valadi et al 2007). Exosomes are 
released by epithelial cells (Kapsogeorgou et al 2005, van Niel et al 2001), found in 
bronchoalveolar lavage fluids (Admyre et al 2003) and also in the apical secretions 
from human bronchioalveloar epithelial (HBE) cultures (Kesimer et al 2009, Pillai et 
al 2014). The presence of exosome asssociated proteins in our mMEC secretome 
further adds to the potential utility of this model to study the role of exosomes in 
middle ear biology and OM pathogenesis. 
Infection of mMECs using the human otopathogen, NTHi demonstrates that our 
culture system can be effectively utilised for the study of host pathogen interactions 
within the middle ear. Our studies show that, NTHi initially infected a small number of 
cells in culture and the infection spread laterally over time. Since the advent of 
pneumococcal vaccines, NTHi is the most common pathogen in OM (Casey & 
Pichichero 2004). Epithelial remodelling, one of the most common features of OM, is 
characterised by mucous metaplasia. The chemokine Cxcl2/MIP2α is the murine 
homologue of IL-8 and is a key mediator of overproduction of mucin (Juhn et al 
2008). NTHi infection is known to stimulate Cxcl2 upregulation in several murine 
tissues including the middle ear, lungs and the inner ear (Gaschler et al 2009, Lim et 
al 2007, Woo et al 2012). Moreover, Cxcl2 was identified as the most upregulated 
gene when mice were trans-tympanically injected with NTHi and on infection of the 
mouse middle ear epithelial cell line (mMEEC) with NTHi (Preciado et al 2013). Our 
data shows that Cxcl2 was significantly upregulated on NTHi infection at 24 and 48 
hours post infection, suggesting that our mMECs respond to bacterial infection in a 
manner similar to the native middle ear epithelium. This opens up a new avenue to 
utilise this system to study the response of middle ear cells to different insults, 
injuries and infections. Our mMEC cultures can potentially be utilised to  study the 
interaction of host middle ear epithelial cells with a variety of bacterial as well as viral 
otopathogens. 
Previous studies have demonstrated successful gene silencing in primary HBE cells 
and mTECs using lentiviral transduction systems (Horani et al 2012, Vladar & 
Stearns 2007). Recently the CRISPR/CAS9 genome editing system was utilised in 
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HBE cells and mouse tracheal organoid cultures in order to study genes involved in 
the regeneration of basal cells into mucocilliary cells of the airway epithelium (Gao et 
al 2015). The physiological similarities of mMEC cells with airway epithelial cells and 
the use of similar culture conditions for their growth means that the mMEC model 
might be amenable to gene editing studies in future.  
It is known that primary airway epithelial cells cultured from cystic fibrosis and 
asthma patients maintain the disease phenotype in culture (Davies et al 2003, 
Matsui et al 1998). A number of mouse models are available for the study of OM. 
These include mice deficient in innate immunity genes such as Evi1, Fbxo11, TLRs 
and Myd88, cilliary development genes such as Dnahc5 (Rye et al 2011) and goblet 
cells (Roy et al 2014). It will be interesting to see if our mMEC culture system can be 
utilised to reproduce the OM phenotype of these mouse mutants in vitro and enable 
comparative studies between unaffected and diseased cultures. OM often involves  
complex responses involving the middle ear epithelium, sub-epithelial mesenchyme, 
inflammatory cells and middle ear effusion, making it challenging to identify epithelial 
cell-specific responses. The mMEC culture system will provide us with the ability to 
isolate and assay responses of specific sub poupulations of epithelial cells. Our cell 
isolation method eliminates the influence of explants and excludes fibroblasts from 
culture, which were two of the most important confounding factors showin in previous 
studies of primary middle ear epithelial cells. It is a 3-dimentional model of the middle 
ear epithelium and hence mimics the in vivo physiology more closely compared to 
cell lines. The possibility of replicating the phenotype of the genetic models of OM, 
the capacity to easily manipulate differentiation of cells by modifying culture 
conditions and the ability to infect cells with various ototpathogens makes our model 
widely applicable to the wider OM community. The availability of such a well-
characterised model of the middle ear epithelium can help better understand the cell 
biology of the middle ear and improve our understanding of the pathogenesis of OM.  
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Materials and Methods 
 
Ethics statement 
Humane care and animal procedures were carried out in accordance to the 
appropriate UK Home Office Project licence. Randomised male and female 8-10 
week old C57BL/6 and C3H/HeH mice, housed in individually ventilated cages 
(Techniplast UK Ltd) under specific pathogen free (SPF) conditions were obtained 
from MRC Harwell, UK. 
 
Dissection of the middle ear cavity 
The detailed protocol used for dissection is outlined in Fig S5. Mice were euthanized 
by terminal intra-peritoneal injection of 100μL pentobarbital (50mg/ml, Henry 
Schein®) and exsanguinated by cutting the inferior vana cava. Mice were 
decapitated, the skin at the nape of the neck was incised, bisected anteriorly and 
removed entirely to expose the bony surface of the skull and the lower jaw was 
detached under direct visualization. Under a dissecting microscope (Olympus 
SZx10), the skullcap was gently opened with a pair of fine forceps and the brain was 
removed. The head was bisected at midline and oriented with the opening of the ear 
facing upwards. Any muscle, soft tissue and remnant hair surrounding the ear were 
removed using fine dissecting scissors and forceps, leaving the MEC (bulla), still 
attached to the outer ear canal (OEC) and the inner ear (IE). The bony shell of the 
bulla was further cleaned free of any attached extraneous tissue. The OEC, which 
appears a shade lighter than the MEC, was gently broken away from the MEC using 
stork bill forceps. The tympanic membrane and the ossicles usually detached from 
the MEC along with the OEC. Alternatively, they were physically removed using fine 
stork bill forceps. Lastly, the cup-shaped MEC was carefully lifted away from the 
inner ear.  
 
Isolation and differentiation of middle ear epithelial cells at air liquid interface 
The protocol for primary culture and differentiation of mouse middle ear epithelial 
cells (mMECs) was adapted from a previously described method for  
mTECs; (You & Brody 2013, You et al 2002). For each batch of cells, bullae from 
approximately six mice (12 bullae) were pooled in a tube containing pronase (1.5 
mg/ml) in ‘mMEC basic media’: DMEM/F-12 HAMs media (Life Technology, Cat No- 
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31330-038) supplemented with penicillin (100 µg /ml) and streptomycin (100 µg/ml) 
(Life Technology, Cat No- 15070-063) and subjected to overnight proteolysis at 4°C. 
The pronase was neutralised by the addition of 10% foetal bovine serum (FBS) and 
the bullae were gently agitated by inverting the tube 25 times. The bullae were then 
transferred to 2ml of fresh mMEC basic 10% FBS media, the tube was inverted 
again 25 times and this process was repeated 3 times. The combined proteolytic and 
mechanical actions led to dissociation of the middle ear cells from the bullae (Fig. 
S6). Media from the three tubes was combined and centrifuged at 500g for 10 
minutes at 10°C. The pelleted cells were re-suspended in 1ml of media containing 1 
mg/ml bovine serum albumin (BSA) and 0.5 mg/ml DNase I (Sigma-Aldrich, Cat No- 
DN25). Cell viability and number were assessed using trypan blue staining and a 
haemocytometer. Cells were centrifuged at 500g for 5 minutes at 10°C and the pellet 
re-suspended in 5ml of mMEC basic 10% FBS media. In order to seperate 
contaminating fibroblasts from epithelial cells a differential adherence step was 
performed by plating the cells on 60mm surface treated tissue culture dishes at 37°C 
in a 5% CO2 incubator for 3-4 hours. Fibroblasts attached to the plastic whilst the 
non-adherent epithelial cells were collected, centrifuged at 500 xg for 5 minutes at 
10°C and re-suspended in 1ml of ‘mMEC plus’ media: mMEC basic media 
supplemented with 5% FBS, 30 µg/ml bovine pituitary extract (Life Technology, Cat 
No- 13028-014), 10 µg/ml of insulin (Sigma-Aldrich, Cat No- I1882), 25 ng/ml of 
mouse epidermal growth factor (BD Biosciences, Cat No- 354001), 5 µg/ml of 
transferrin (Sigma-Aldrich, Cat No- T1147), 0.1 µg/ml of cholera toxin (Sigma-
Aldrich, Cat No- C8052) and 0.01 µM of freshly added retinoic acid (Sigma-Aldrich, 
Cat No- R2625).  
For optimisation of culture conditions, cells were plated on either tissue culture 
plastic or sterile, 0.4μm pore sized transparent PET (Polyethylene Terephthalate) 
membranes coated with 150μL (50μg/ml) of rat-tail collagen type I (BD Biosciences, 
Cat No- 354236) in a 24-well supported transwell format (Falcon, Cat No-353095).  
mMECs were seeded at an initial density of 1 x 104 and 2 x 104 cells/well in the 
presence or absence of 10 μM of Rho Kinase inhibitor, Y-27632 dihydrochloride 
(ROCKi, Tocris bioscience, Cat- 1254) and 5 x 104 cells/well without ROCKi. A 
seeding density of 1 x 104 cells/well with ROCKi on transwell membranes was 
identified as optimum and therefore used for culturing all following batches of cells 
(Fig. S3A-G). An average of 671,788 ± 59,790 (n=9 batches) cells were obtained 
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from 12 pooled bullae. 30 to 35 transwells were typically seeded at this density and 
the remaining cells were lysed in Trizol reagent (Sigma- Aldrich, Cat No- T2494) to 
give freshly isolated mMEC original cells for comparison with the cultured cells. 
Cells were initally cultured, submerged, in ‘mMEC plus-proliferation media’ with 300 
μL of media in the top chamber and 700 μL in the bottom chamber.  Media was 
changed every 48 hours, until the cells were completely confluent, thereafter media 
from the apical chamber was removed and media in the basal chamber was 
replaced with ‘mMEC SF- differentiation media’: DMEM/F-12 media supplemented 
with 1 mg/ml BSA (Life Technology, Cat No- 31330-038), 5 µg/ml insulin, 30 µg/ml 
bovine pituitary extract, 5 µg/ml transferrin, 5 ng/ml mouse epidermal growth factor, 
0.025 µg/ml cholera toxin and freshly added 0.01 µM retinoic acid to induce ALI 
culture. This system of culture promotes differentiation of cells by mimicking the in 
vivo situation. Cells were differentiated at ALI for 14 days and media was changed 
every 48 hours. Cells were lysed in 250 µL of Trizol reagent for RNA extraction and 
apical washes were collected in 200 µL of sterile HBSS at ALI Day 0 (submerged 
Day 10), Day 3, Day 7 and Day 14. Figure 2A gives a brief overview of the complete 
cell culture system. Doubling time for cells seeded at 5 x 104 cells/well in mMEC- 
Plus media without ROCKi was determined by trypsinizing the cells and using the 
formula: PD = t x Log2/(LogC2-LogC1) [PD = Population doubling, t = 48 hours, Log 
= 10 based Log, C1 = initial cell count, C2 = final cell count]. 
 
Immunoflorescence microscopy 
Transwell membranes at ALI Day 0 and Day 14 were fixed with 10% phosphate 
buffered formalin at 370C for 30 minutes. Cells were permeabilised using 0.5% Triton 
X-100. Non-specific binding was blocked using 10% goat serum in PBS and 
incubation for 1 hour at 80rpm on an orbital shaker at room temperature. The 
membranes were washed 3 times with PBS for 5 minutes at 150 rpm and incubated 
with the following primary antibodies: anti-Bpifa1 (1:200), anti-Foxj1 (1:300), anti- 
p63 (1:100), anti-MUC5B (1:100), anti-ZO1 (1:200), anti-lacto transferrin (1:200) or 
anti-Reg3γ (1:200), overnight at 40C at 80rpm on the shaker. All antibody details are 
given in Table S2. The following day, membranes were washed 3 times with PBS for 
5 minutes at 150 rpm and bound primary antibodies detected using 1:200 dilution of 
the appropriate fluorophore-tagged secondary antibody (Alexa-Fluor 568 Goat anti-
rabbit antibody (Cat No- A11011) or Alexa Fluor 488 Goat anti-mouse antibody (Cat 
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No- A11001)) incubated for 1 hour at room temperature at 80 rpm in the dark. 
Membranes were washed 3 times as above, detached carefully from their transwell 
support with a fine scalpel and placed on a glass microscope slide with the cells 
facing upwards. Nuclei were counterstained using Vectashield DAPI mounting 
medium (Vector laboratories) and the cells imaged using an Olympus Fluoview 1000 
Confocal microscope. 
 
Scanning Electron Microscopy 
ALI Day 0 and Day 14 cell membranes were washed free of culture media with 
sterile, warm HBSS and fixed in 3% Glutaraldehyde in 0.1M Sodium Cacodylate 
buffer overnight at 40C. The membranes were washed 2 times with 0.1M Cacodylate 
buffer for 5 minutes each, detached from their transwell support as described above 
and postfixed in 2% aqueous Osmium tetroxide. The specimens were washed briefly 
in water, dehydrated in a graded ethanol series, dried in a 1:1 mixture of 100% 
ethanol: Hexamethyldisilazane (HEX) before final drying in 100% HEX. The 
membranes were placed overnight in a fume hood, mounted onto a pin-stub using a 
Leit-C sticky tab, (gold sputter coated) and examined using a Philips XL-20 SEM at 
15kV.  
 
Transmission Electron Microscopy  
ALI Day 14 cell membranes were fixed with 3% Glutaraldehyde in 0.1M Sodium 
Cacodylate buffer, washed and post fixed in 2% Osmium Tetroxide as mentioned 
above. The detached membranes were washed briefly in water and dehydrated 
through graded ethanols, cleared in Epoxy-propane (EPP) and infiltrated in 1:1 
mixture of araldite resin: EPP mixture overnight on a rotor.  This mixture was 
replaced in two changes with fresh araldite resin mixture over an 8-hour period, 
before being embedded and cured at 600C in an oven for 48-72 hours. Ultrathin 
sections (approximately 85nm thick) were cut on a Leica UC 6 ultra-microtome onto 
200 mesh copper grids, stained for 30 minutes with saturated aqueous Uranyl 
Acetate followed by Reynold’s Lead Citrate for 5minutes. Sections were examined 
using a FEI Tecnai Transmission Electron Microscope at an accelerating voltage of 
80Kv. Electron micrographs were recorded using a Gatan Orius 1000 digital camera 
and Digital Micrograph software. 
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Non-typeable Haemophilus influenzae infections 
mMECs were cultured in antibiotic-free media for 48 hours prior to infection. A GFP 
tagged, streptomycin resistant strain of the clinical OM isolate, NTHi-375 (NTHi 
375SR), derived from a Finnish pneumococcal vaccine study on children undergoing 
tympanocentesis in 1994-95 was used for all bacterial challenge experiments (Cody 
et al 2003). NTHi 375SR was grown from glycerol stocks on brain heart infusion (BHI) 
agar plates supplemented with 2μg/ml Nicotinamide adenine dinucleotide hydrate 
(NAD, Sigma Aldrich, Cat No- N7004), 2μg/ml hemin (Sigma Aldrich, Cat No- 
H9039) and 200μg/ml streptomycin sulphate (Melford Laboratories, Cat No- S0148) 
at 370C, 5% CO2 overnight. The following day colonies were transferred into BHI 
broth supplemented with NAD and hemin and incubated for 3 hr at 370C, 5% CO2, 
250rpm. The optical density (OD490) of 1ml of liquid culture was 
spectrophotometrically determined (Jenway 6300) and the culture diluted with PBS 
to give a concentration of 1x109 bacteria/ml. An appropriate amount of culture in 
antibiotic-free mMEC-SF media was added to the apical chamber of ALI Day 14 
mMEC cultures such that the membranes were infected at a multiplicity of infection 
(MOI) of 1:100 (mMECs: bacteria). An equal volume of sterile PBS was added to 
generate MOCK infected controls. The membranes were incubated at 370C, 5% CO2 
for 1 hr and washed 3 times with sterile HBSS to remove non-adherent bacteria. 
Media was replaced in the basal chamber and cultures were incubated for 4, 24, 48 
and 72 hours post infection (hpi). At each time point apical washes were collected, 
cells were lysed in Trizol reagent for RNA extraction and membranes were fixed for 
IFC as described. Membranes were visualized using confocal microscopy and 
infection was quantified by measuring the mean integrated fluorescence intensity of 
four central 10x fields at each time point, in each batch, using Image J software.  
 
Reverse transcription PCR (RT-PCR) 
For end-point RT- PCR, total RNA was extracted from at least 3 batches of freshly 
mMEC original cells and mMECS at ALI days 0 and 14 lysed in Trizol. RNA yield 
was determined using NanoDrop-1000 (Thermoscientific). Residual genomic DNA 
was digested by DNase I treatment (Promega, Cat No-M6101) and 200ng of RNA 
was reverse transcribed using AMV Reverse Transcriptase  (Promega, Cat No- 
M9004). RT-PCR was performed with 1µl of template cDNA and Maxima Hot Start 
Green PCR Master Mix (ThermoFisher Scientific, Cat No- K1061). The cycling 
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conditions were: 95°C for 5 minutes; denaturation: 94°C for 1 minute (25-35 cycles); 
annealing: 60°C for 1 minute; extension: 72°C for 1 minute; final extension: 72°C for 
7 minutes (MJ Research PTC-200). The primer pairs used are described in Table 
S3. The amplified PCR products were run on a 2% agarose gel containing 0.5µg/ml 
ethidium bromide (Dutscher scientific, Cat No- 4905006) and bands visualised using 
a Biorad ChemiDoc™ XRS+. 
 
Real time quantitative PCR (RT-qPCR) 
For RT-qPCR, total RNA was extracted from at least three independent batches of 
ALI Day 14 cultures infected with NTHi-375SR for 24 and 48 hours and their 
corresponding MOCK infected cultures. Residual genomic DNA was removed using 
the DNA-free™ kit (Life technologies, Cat No- AM1906), RNA quantified using 
NanoDrop-8000 (Thermoscientific) and integrity checked on an Agilent Bioanalyzer 
2100 instrument using RNA 6000 Nano kit. 400ng of total RNA was reverse 
transcribed into cDNA in a 20µL reaction volume using a Superscript™ III First 
Strand Synthesis kit (Invitrogen, cat No- 11752-050), in accordance with 
manufacturer’s instructions. RT-qPCR was performed using an Applied Biosystems 
TaqMan gene expression assay for Cxcl2 (Mm00436450_m1) on a 7500 Fast Real 
Time PCR system (Applied Biosystems), with 2x Taqman Fast Universal Master Mix 
(Applied Biosystems, Cat No- 4352042). 10ng cDNA was added to each reaction 
and three technical replicates were performed for each assay in each batch. Genetic 
expression levels of Cxcl2 were normalized to three endogenous controls: ATP5B, 
CyC1 (Primerdesign geNormTM Reference Gene Selection Kit) and Ppia (TaqMan 
assay (Mm02342429_g1) and analysed using ABI 7500 software v2.0.1 using the 2-
∆∆Ct method. Data is presented as mean Relative quantification (RQ) and error bars 
represent standard error of mean.  
 
Western Blotting 
Standard western blotting technique was used to detect secreted proteins in apical 
HBSS washes collected at ALI D0, D3, D7 and D14 from the mMEC cultures. An 
equal volume of 2x SDS loading buffer (20% SDS, 1M DTT, Glycerol, Tris-HCl 0.5M 
pH6.8, 0.2% bromophenol blue, protease inhibitors) was added to the wash and 
denatured at 95°C for 5 minutes. 40 µL of total sample was resolved on a 12% 
polyacrylamide gel, transferred to a PVDF membrane using a semi dry blotting 
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system (Biorad Trans-blot turbo) and probed with primary antibodies (anti-Bpifa1 
(1:200), anti-lacto transferrin (1:2000), and anti-REG3γ (1:5000) overnight at 4°C. 
The primary antibody was detected using a polyclonal goat anti-rabbit secondary 
antibody (Dako P0448) conjugated with HRP (1:2000). Primary antibody details are 
described in Table S1. Protein bands were visualised using the EZ system 
(Geneflow, Cat No- 30500500B). 
 
Immunohistochemistry 
Formalin fixed, paraffin embedded serial sections of the mouse head passing 
through the middle ear cavity were deparaffinised and dewaxed in a 100% Xylene 
(Sigma, UK) and rehydrated in 100% Ethanol (Fischer Scientific, UK). Endogenous 
peroxidase activity was blocked using 0.3 % H2O2- Methanol (Fischer Scientific, UK). 
Non-specific binding was blocked by incubating the sections in 100% goat serum for 
30 minutes at room temperature. Sections were washed and incubated in anti-Bpifa1 
primary antibody (1:750) overnight in a humified chamber at 4◦C. The following day, 
sections were washed twice in PBS, incubated in 0.5% biotinylated polyclonal goat 
anti-rabbit secondary antibody (VectastainR EliteR ABC kit, Cat No- PK-6101) for 30 
minutes at room temperature, followed by incubation with the ABC reagent for signal 
amplification for 30 minutes. NovaRed mixture (Vector, Cat No- SK 4800) was used 
for colour development. Sections were counterstained using Harris’s Haematoxylin 
(Thermo Scientific), differentiated in acid alcohol, treated with Scott’s tap water, 
dehydrated in 95% to absolute ethanol, cleared using Xylene (Leica, Cat No- ST 
4020), mounted in DPX (Leica Biosystems) and visualized and imaged using a light 
microscope (Olympus BX61). 
 
Sample preparation for Mass Spectrometry 
Apical wash secretions from 6 batches of ALI Day 14 mMEC cultures were pooled. 
TCA precipitation was performed (30% TCA in acetone) at -20°C for 2 hours to 
precipitate soluble proteins (50 µg). Proteins were pelleted at 12,000 g for 10 
minutes (4oC) and pellets washed three times with ice-cold acetone, air dried and. 
re-suspended in 50 mM ammonium bicarbonate, 0.1 % RapiGest SF (waters). 
Samples were heated at 80°C for 10 minutes, reduced with 3 mM DTT at 60°C for 
10 minutes, cooled and then alkylated with 9 mM iodoacetamide (Sigma) for 30 
minutes. All steps were performed with intermittent vortexing. Proteomic-grade 
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trypsin (Sigma) was added at a protein: trypsin ratio of 50:1 and incubated at 37°C 
overnight. The samples were precipitated using 1% TFA at 37°C for 2 hr and 
centrifuged at 12,000 g for 1 hr (4°C) to remove RapiGest SF. The peptide 
supernatant was desalted using C18 reverse-phase stage tips (Thermo Scientific 
Pierce) according to the manufacturer’s instructions, dried and re-suspended in 3% 
(v/v) acetonitrile, 0.1% (v/v) TFA for analysis by Mass Spectrometry (MS).  
 
NanoLC-MS ESI MS/MS analysis 
Peptides were analysed by on-line nanoflow LC using the Thermo EASY-nLC 1000 
LC system (Thermo Fisher Scientific) coupled with Q-Exactive mass spectrometer 
(Thermo Fisher Scientific). Samples were loaded onto an Easy-Spray C18 column 
(50cm, i.d. 75 µm), fused to a silica nano-electrospray emitter (Thermo Fisher 
Scientific). Chromatography was performed at 35°C with a buffer system consisting 
of 0.1% formic acid (buffer A) and 80% acetonitrile in 0.1% formic acid (buffer B). 
The peptides were separated over a 97 minute linear gradient of 3.8 – 50% buffer B 
at a flow rate of 300 nL/min. The Q-Exactive was operated in data-dependent mode 
with dynamic exclusion and survey scans acquired at a resolution of 70,000. The 10 
most abundant isotope patterns with charge states +2, +3 and/or +4 from the survey 
scan were selected with an isolation window of 2.0Th and fragmented by higher 
energy collisional dissociation with normalized collision energies of 30. The 
maximum ion injection times for the survey scan and the MS/MS scans were 250 
and 100ms, respectively, and the ion target value was set to 1E6 for survey scans 
and 1E4 for the MS/MS scans. 
 
Protein Identification and Quantification 
Thermo RAW files were imported into Progenesis LC–MS (version 4.1, Nonlinear 
Dynamics) and only peaks with a charge state between +2 and +7 were picked. 
Spectral data were exported for peptide identification using the Mascot (version 
2.3.02, Matrix Science) search engine. Tandem MS data were searched against 
translated ORFs from the mouse genome (Uniprot release 2015_02; 16,868 
sequences; 9,451,355 residues). The search parameters were as follows: precursor 
mass tolerance was set to 10 ppm and fragment mass tolerance was set to 0.8 or 
0.01Da and two missed tryptic cleavages were permitted. Carbamidomethylation 
(cysteine) was set as a fixed modification and oxidation (methionine) set as variable 
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modification. Mascot search results were further validated using the machine-
learning algorithm Percolator embedded within Mascot. The Mascot decoy database 
function was utilised and the false discovery rate was <1%, while individual 
percolator ion scores> 13 indicated identities or extensive homology (p <0.05). 
Mascot search results were imported into Progenesis LC–MS for relative 
quantification using non- conflicting peptides.  
 
Statistics 
A paired two tailed Students t-test was used to compare relative Cxcl2 expression 
between the MOCK infected and NTHi infected samples at each time point. Data 
was presented using GraphPad Prism version 6.0. 
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Figures 
 
 
 
 
Fig. 1: Primary culture of mouse middle ear epithelial cells. Timeline for culture 
of mMECs is shown above (A). Bullae were dissected, treated with pronase for 
dissociation of the middle ear epithelial cells and fibroblasts were excluded from 
culture by differential adherence to plastic. Epithelial cells were grown in submerged 
culture till confluence, before ALI was induced. Samples for transcriptional and 
proteomic analysis were collected at regular time points. Phase contrast images 
showing cells in culture under 10x magnification (B-I). In the proliferative submerged 
conditions, a small number of cells attached to form epithelial islands 3 days after 
seeding (B) The cells proliferated faster from day 5 (C) through day 7 (D) and formed 
a confluent monolayer at day 9. This was termed as ALI Day 0 (E) Morphology of 
cells changed from ALI Day 3 (F) and clusters of compactly arranged cells started 
forming at ALI Day 7 (G). ALI Day 14 cultures were composed of flat polygonal and 
compactly clustered pseudo stratified cells with active cilia. White arrowheads mark 
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elevated ciliated cells and asterisk mark flatter polygonal cells. (H). Fibroblasts 
cultured on plastic plates through differential adhesion method (I) Scale bar = 200 
μm. 
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Fig. 2: Electron microscopy of mMEC cultures. Scanning electron microscopy of 
ALI Day 0 mMEC cultures showing large flat polygonal cells with apical microvilli (A) 
ALI Day 14 cultures showing dome shaped cells at higher magnification (B) and 
combination of interspersed flat polygonal and densely ciliated cell populations a 
lower magnification (C) resembling the morphology of native middle ear epithelium 
(D). Cracks developed in the membrane are due to processing of samples for SEM. 
White arrowheads mark elevated ciliated cells and asterix mark flatter polygonal 
cells.  Transmission electron microscopy of ALI Day 14 mMEC cultures showing 
adjacent ciliated and secretory cells and formation of tight junctions demonstrated by 
presence of desmosomes (asterisk). Arrow shows cilia (E). Immunoconfocal 
microscopy image showing formation of tight junctions marked by ZO1 positive 
staining. Area beyond white lines indicates a cross section through the membrane. 
(n=3) Scale bar =10 μm (A,C,D)  ; 5 μm (B); 1 μm (E); 50 μm (F). 
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Fig. 3: Expression of epithelial markers in mMEC cultures. End-point RT-PCR 
showing expression of a selected panel of upper airway associated genes in mMEC 
original cells isolated from the middle ear cavity, ALI D0 cells and ALI D14 cells. 
Expression profile of ALI Day 14 cells was similar to mMEC original cells isolated 
from the middle ear for most genes (A). Detection of Bpifa1 (B), Lactotransferrin (C) 
and Reg3ϒ (D) in the apical washes from differentiating cells using Western blotting 
technique. Data is representative of three independent cultures. 
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Fig. 4: Localisation of epithelial markers in mMEC cultures. 
Immunofluorescence confocal images (representative of three independent batches) 
showing abundant expression of the basal cell marker, P63; limited expression of the 
secretory protein, Bpifa1 (A), no expression of goblet cell marker, Muc5B and the 
ciliated marker, FoxJ1 (C) in undifferentiated ALI Day 0 mMEC cultures (A and C). 
Differentiated mMEC ALI Day 14 (B, D, E, F) cultures showing expression of 
secretory cells positive for Bpifa1 (B), Lactotransferrin (E), Reg3γ (F), goblet cells 
positive for Muc5B and ciliated cells positive for FoxJ1 (D). Area beyond white lines 
indicates a cross section through the membrane. High magnification. Z-stack cross 
sections of nuclei stained with DAPI shows that ALI Day 0 cells form a flat monolayer 
(G) whereas ALI Day 14 cells are a combination of pseudostratified elevated cells 
(arrowheads) and flatter cells (asterisk) (H).  Scale bar =50μm. 
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Fig. 5: Distribution of cell types in mMEC cultures. Low powered (20x) 
immunofluorescence confocal images representative of 3 independent batches of 
ALI Day 14 mMEC cultures showing a combination of flat cells and clusters of 
elevated cells at slightly different foci. Ciliated cells (FoxJ1) do not co-localise with 
and goblet cells (Muc5B) (A) and Bpifa1 expressing cells (B) Scale bar =100μm. 
High magnification (60x) cross section Z-stack confocal images showing that FoxJ1 
and Muc5B expression is mostly restricted to the elevated cell types  (arrowheads) 
(C) and Bpifa1 is predominantly expressed by flatter cells (asterisk) (D) Scale bar = 
50μm (C,D). 
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Fig. 6: mMEC cultures serve as an otopathogenic infection model. High 
magnification (60x) confocal images representative of n=3 independent batches of 
ALI Day 14 mMECs infected with GFP tagged NTHi-375SR for 24 hours (A), 48 
hours (B) and 72 hours (C) showing a time dependent increase in bacterial infection. 
Control ALI Day 14 mMECs mock infected for 72 hrs (D) Scale bar =50μm. Increase 
in mean green fluorescence intensity from 24hpi to 72hpi quantified from lower 
magnification (10x) images from three independent batches, suggesting 
demonstrating an increase is the amount of bacteria infecting the cultures with time 
(E). Relative gene expression of Cxcl2 (F) in infected mMEC cultures compared with 
MOCK infected cultures at 24 and 48 hours post infection. Expression of target gene 
Cxcl2 was normalized to 3 endogenous controls: ATP5B, CyC1 and Ppia and plotted 
relative to the 24hpi MOCK sample. Data is  analysed using two tailed student’s t-
test and represented as mean relative quantification (RQ) ± SEM for three 
independent batches of cultures. *: p<0.05 **p<0.01 ***p<0.005. 
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Table 1: Most abundant secreted proteins identified in apical ALI Day 14 
washes from mMEC cultures 
Accession 
Number 
Protein 
Peptide 
count 
emPAI 
Score 
Biological reference 
P08071 Lactotransferrin 47 202.53 Anti-microbial iron chelation 
Q921I1 Serotransferrin 40 29.58 Iron chelation, cell proliferation 
O09049 
Regenerating islet-derived 
protein 3-gamma 
8 11.38 Anti-microbial 
P11672 
Neutrophil gelatinase-
associated lipocalin 
9 10.45 Iron trafficking, innate immunity 
Q61147 Ceruloplasmin 55 10.1 
Copper transport, antioxidant 
defence 
P97361 
BPI fold-containing family 
A member 1 
9 4.74 
Suggested role in innate 
immunity 
P01027 Complement C3 111 4.68 Activates complement system 
P06797 Cathepsin L1 12 3.11 Lysosomal protein degradation 
Q61805 
Lipopolysaccharide-
binding protein 
19 2.96 
Antimicrobial activity through 
bacterial LPS binding 
P10605 Cathepsin B 15 2.47 
Intracellular protein degradation 
and turnover 
Q61362 Chitinase-3-like protein 1 22 2.16 
Tissue remodelling in response 
to environmental stress, 
activation of NfκB signalling 
pathway 
P25785 
Metalloproteinase inhibitor 
2 
14 2.08 Inactivates metalloenzymes 
Q9CQV3 Serpin B11 24 1.97 Serine protease inhibitor 
P18242 Cathepsin D 20 1.67 Intracellular protein breakdown 
O88312 
Anterior gradient protein 2 
homolog 
10 1.53 
Regulates giblet cell 
differentiation and mucous 
secretion. 
P50404 
Pulmonary surfactant-
associated protein D 
23 1.5 
Innate immunity response, 
respiratory gaseous exchange 
and homeostasis 
P10810 
Monocyte differentiation 
antigen CD14 
16 1.41 
TLR2 mediated innate immune 
and inflammatory response to 
bacterial LPS in concert with 
LBP 
Q62426 Cystatin-B 6 1.24 Proteinase inhibitor 
Q9ER10 
Brain-specific serine 
protease 4 
15 1.11 Protease activity 
P08905 Lysozyme 10 1.05 Bacteriolytic activity 
Q9DAU7 
WAP four-disulfide core 
domain protein 2 
6 0.91 Protease inhibitor 
P11214 
Tissue-type plasminogen 
activator 
31 0.89 
Tissue remodelling, cell 
migration 
Q9WUU7 Cathepsin Z 14 0.89 Peptidase activity 
O88593 
Peptidoglycan recognition 
protein 1 
10 0.81 
Triggers apoptosis of Gram 
positive bacteria 
Q60854 Serpin B6 23 0.81 Regulation of serine proteases 
P34884 
Macrophage migration 
inhibitory factor 
5 0.61 
Pro inflammatory cytokine 
involved in regulation o 
macrophage activity 
Q9R118 Serine protease HTRA1 21 0.54 
Cell proliferation and viral 
response 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
P12032 
Metalloproteinase inhibitor 
1 
12 0.49 
Cell differentiation and wound 
healing 
P97430 Antileukoproteinase 11 0.49 Anti microbial host defence 
P61939 Thyroxine-binding globulin 22 0.4 Thyroid hormone transport 
P25085 
Interleukin-1 receptor 
antagonist protein 
7 0.35 Inhibits IL-1 activity 
P70124 Serpin B5 22 0.35 Morphogenesis of epithelium 
Q61703 
Inter-alpha-trypsin inhibitor 
heavy chain H2 
48 0.24 Hyaluronan metabolic process 
P97290 
Plasma protease C1 
inhibitor 
25 0.12 
Blood coagulation, complement 
activation. 
   NB- Acession numbers and biological functions from the UniProt database 
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Fig. S1: Expression of Bpifa1 in WT middle ear epithelium 
Bpifa1 expression was detected in the Wt mouse middle ear using 
immunohistochemistry. Low magnification image showing expression of Bpifa1 all 
along the middle ear epithelium (A). Bpifa1 is secreted by non-ciliated cells of the 
middle ear epithelium (B), but it coats the surface of the cilia (C). Negative controls 
showed absence of staining (D, E). 
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Fig. S2: Progression of NTHi infection in mMEC cultures 
Low power confocal images of ALI Day 14 mMEC cells infected with GFP tagged 
NTHI-375SR at 24 hpi (A), 48hpi (B) and 72 hpi (C). Each panel represents 4 central 
fields at 10x magnification spanning approximately 50% of the membrane. The 
amount of infection at each time point was quantified as a measure of the mean 
integrated intensity for green fluorescence in these panels from 3 independent 
batches of infections. Scale bar = 200 μm 
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Fig. S3: Optimisation of seeding density for mMEC culture 
Phase contrast images of ALI Day 14 mMEC cells in culture seeded at various 
densities in absence and presence of ROCKi (A- G). On plastic, both in absence (A) 
and presence (E) of ROCKi, cells did not exhibit the typical epithelial morphology, 
started forming vacuoles, detached from the surface and did not achieve confluence. 
In absence of ROCKi, at 1 x104 cells/ well (B) cells grew in small epithelial clusters 
but did not form a confluent monolayer, at 2 x104 cells/ well (C) a proportion of wells 
formed a confluent monolayer at submerged Day 15 and at 5 x104 cells (D), cells 
formed a confluent monolayer around submerged Day 9. The cells differentiated on 
ALI and demonstrated a typical cobbled stone appearance. In presence of ROCKi, 
both at 1 x104 cells/ well (F) and 2 x104 cells/ well (G), the cells formed a confluent 
monolayer in submerged culture by day 9-10. By ALI Day 14, the cells differentiated 
into various cell types and exhibited cobbled stone appearance typical of epithelial 
cells. Scale bar = 200 μm. White arrowheads indicate elevated clusters of cells with 
actively beating cilia and asterisk denote flatter polygonal cells. RT PCR of ALI Day 
14 samples (H) demonstrating that adding ROCKi to the culture medium did not 
affect differentiation into secretory and ciliated cell types. Seeding density of 1 x104 
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 cells/ well with ROCKi was selected in order to maximize the utility of the isolated 
cells. 
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Fig. S4: Distribution of ciliated cells in WT native mouse middle ear cavity 
Scanning electron microscopy images showing the distribution of ciliated cells in 
various parts of the native WT middle ear cavity. Areas near the Eustachian tube 
were lined with tracts of dense ciliated cells (A). The central part of the middle 
consists of flat polygonal cells interspersed with clusters of short and long ciliated 
cells (B), similar to what is seen in our mMEC cultures. Areas towards the tympanic 
membrane exhibit patches similar to central part of the middle ear as well as larger 
patches of flat polygonal cells with apical microvilli (C). Scale bar = 10 μm 
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Fig. S5: Dissection and isolation of the mouse middle ear cavity 
Wild type C57Bl/6J or C3HeH mice (A) were decapitated (B). The head was skinned 
(C) and skull cap removed (D). Dorsal (E) and ventral (F) view of the head after 
removing the brain, showing the bullae or middle ear cavities, MECs. Bisected head 
showing the outer ear, OE (G). Under dissecting microscope the bullae were 
separated from surrounding tissue (H). The MEC is attached to the outer ear cavity 
(OEC) at the tympanic membrane (Tm) and tapers towards the opening of the 
Eustachian tube (ET) near its posterior end (I). Removal of the OEC and the Tm 
reveals the cochlea of the inner ear on the ventral side of the MEC (J) The cup 
shaped MEC was detached from the inner ear (K) Tissue was dissected along the 
dotted lines. 
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Fig. S6: Effect of Pronase treatment on the middle ear epithelial cells 
Haematoxylin and eosin staining of dissected middle ear cavities showing intact 
middle ear epithelium before proteolytic treatment with pronase (A) and loss of the 
epithelial lining after treatment with pronase and mechanical agitation (B) during the 
cell isolation process suggesting that our isolation protocol successfully dissociates 
middle ear epithelial cells for culture. Scale bar = 200μm 
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Movie S1: Time lapse images showing ciliary beating in live ALI Day 14 mMEC 
cells 
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 Table S1: Proteins identified by MS analysis of ALI Day 14 mMEC apical 
washes 
 
Accession 
Number Protein Name Gene name 
Peptide 
count emPAI 
P08071 Lactotransferrin  TRFL_MOUSE 47 202.53 
Q921I1 Serotransferrin  TRFE_MOUSE 40 29.58 
O09131 
Glutathione S-transferase 
omega-1  GSTO1_MOUSE 17 28.64 
P60710 Actin, cytoplasmic 1  ACTB_MOUSE 23 24.63 
P50446 
Keratin, type II cytoskeletal 
6A  K2C6A_MOUSE 35 19.14 
P08074 
Carbonyl reductase 
[NADPH] 2  CBR2_MOUSE 16 19.04 
Q9Z331 
Keratin, type II cytoskeletal 
6B  K2C6B_MOUSE 36 18.18 
P62806 Histone H4  H4_MOUSE 6 17.1 
P10107 Annexin A1  ANXA1_MOUSE 24 14.87 
P11679 
Keratin, type II cytoskeletal 
8  K2C8_MOUSE 33 14.67 
P19001 
Keratin, type I cytoskeletal 
19  K1C19_MOUSE 35 14.07 
Q61781 
Keratin, type I cytoskeletal 
14  K1C14_MOUSE 35 13 
O09049 
Regenerating islet-derived 
protein 3-gamma  REG3G_MOUSE 8 11.38 
P35700 Peroxiredoxin-1  PRDX1_MOUSE 14 11.13 
Q06890 Clusterin  CLUS_MOUSE 22 10.47 
P11672 
Neutrophil gelatinase-
associated lipocalin  NGAL_MOUSE 9 10.45 
Q61147 Ceruloplasmin  CERU_MOUSE 55 10.1 
Q61414 
Keratin, type I cytoskeletal 
15  K1C15_MOUSE 32 9.92 
P17742 
Peptidyl-prolyl cis-trans 
isomerase A  PPIA_MOUSE 14 9.81 
Q922U2 
Keratin, type II cytoskeletal 
5  K2C5_MOUSE 34 8.7 
Q9QWL7 
Keratin, type I cytoskeletal 
17  K1C17_MOUSE 33 7.76 
O08709 Peroxiredoxin-6  PRDX6_MOUSE 15 7.38 
P10649 
Glutathione S-transferase 
Mu 1  GSTM1_MOUSE 18 6.68 
P07356 Annexin A2  ANXA2_MOUSE 23 6.63 
P52480 Pyruvate kinase PKM  KPYM_MOUSE 36 6.57 
P68372 Tubulin beta-4B chain  TBB4B_MOUSE 21 6.13 
Q6ZWY9 Histone H2B type 1-C/E/G  H2B1C_MOUSE 11 6.12 
Q8BND5 Sulfhydryl oxidase 1  QSOX1_MOUSE 43 6.1 
Q9DCV7 
Keratin, type II cytoskeletal 
7  K2C7_MOUSE 35 6.01 
P16858 
Glyceraldehyde-3-
phosphate dehydrogenase  G3P_MOUSE 21 5.87 
Q61398 Procollagen C- PCOC1_MOUSE 23 5.56 
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 endopeptidase enhancer 1  
P07744 
Keratin, type II cytoskeletal 
4  K2C4_MOUSE 31 5.43 
O35639 Annexin A3  ANXA3_MOUSE 24 5.16 
P68033 
Actin, alpha cardiac muscle 
1  ACTC_MOUSE 23 5.06 
P26040 Ezrin  EZRI_MOUSE 39 5.04 
P99024 Tubulin beta-5 chain  TBB5_MOUSE 21 4.94 
Q05816 
Fatty acid-binding protein, 
epidermal  FABP5_MOUSE 9 4.92 
P08249 
Malate dehydrogenase, 
mitochondrial  MDHM_MOUSE 24 4.77 
P97361 
BPI fold-containing family A 
member 1  BPIA1_MOUSE 9 4.74 
P01027 Complement C3  CO3_MOUSE 111 4.68 
Q8BGZ7 
Keratin, type II cytoskeletal 
75  K2C75_MOUSE 36 4.22 
P56480 
ATP synthase subunit beta, 
mitochondrial  ATPB_MOUSE 30 4.18 
P62830 60S ribosomal protein L23  RL23_MOUSE 10 4.08 
P05784 
Keratin, type I cytoskeletal 
18  K1C18_MOUSE 32 3.99 
P50543 Protein S100-A11  S10AB_MOUSE 5 3.92 
P28654 Decorin  PGS2_MOUSE 23 3.86 
P40142 Transketolase  TKT_MOUSE 34 3.7 
Q9QUI0 Transforming protein RhoA  RHOA_MOUSE 13 3.7 
Q8VCT4 Carboxylesterase 1D  CES1D_MOUSE 27 3.69 
Q9Z2K1 
Keratin, type I cytoskeletal 
16  K1C16_MOUSE 35 3.64 
P57780 Alpha-actinin-4  ACTN4_MOUSE 61 3.61 
P17563 Selenium-binding protein 1  SBP1_MOUSE 31 3.49 
P17182 Alpha-enolase  ENOA_MOUSE 28 3.36 
P11499 
Heat shock protein HSP 
90-beta  HS90B_MOUSE 40 3.31 
P08730 
Keratin, type I cytoskeletal 
13  K1C13_MOUSE 31 3.29 
P14211 Calreticulin  CALR_MOUSE 27 3.28 
Q9D379 Epoxide hydrolase 1  HYEP_MOUSE 29 3.27 
P63017 
Heat shock cognate 71 kDa 
protein  HSP7C_MOUSE 37 3.24 
Q00493 Carboxypeptidase E  CBPE_MOUSE 28 3.17 
P06797 Cathepsin L1  CATL1_MOUSE 12 3.11 
P62962 Profilin-1  PROF1_MOUSE 9 3.1 
P27773 
Protein disulfide-isomerase 
A3  PDIA3_MOUSE 35 3.05 
P62908 40S ribosomal protein S3  RS3_MOUSE 19 3.05 
Q7TMM9 Tubulin beta-2A chain  TBB2A_MOUSE 21 3.03 
Q8VDD5 Myosin-9  MYH9_MOUSE 127 3.03 
P09103 Protein disulfide-isomerase  PDIA1_MOUSE 39 3.02 
P68368 Tubulin alpha-4A chain  TBA4A_MOUSE 22 2.99 
P68373 Tubulin alpha-1C chain  TBA1C_MOUSE 22 2.99 
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 Q8VED5 
Keratin, type II cytoskeletal 
79  K2C79_MOUSE 32 2.98 
Q61805 
Lipopolysaccharide-binding 
protein  LBP_MOUSE 19 2.96 
Q9Z1Q5 
Chloride intracellular 
channel protein 1  CLIC1_MOUSE 17 2.96 
Q07797 Galectin-3-binding protein  LG3BP_MOUSE 26 2.94 
Q61646 Haptoglobin  HPT_MOUSE 20 2.94 
Q7TPR4 Alpha-actinin-1  ACTN1_MOUSE 60 2.92 
P62821 Ras-related protein Rab-1A  RAB1A_MOUSE 18 2.9 
O88844 
Isocitrate dehydrogenase 
[NADP] cytoplasmic  IDHC_MOUSE 30 2.87 
P08228 
Superoxide dismutase [Cu-
Zn]  SODC_MOUSE 11 2.78 
P18760 Cofilin-1  COF1_MOUSE 12 2.72 
P19157 
Glutathione S-transferase 
P 1  GSTP1_MOUSE 10 2.71 
Q9R0P5 Destrin  DEST_MOUSE 13 2.7 
P06151 
L-lactate dehydrogenase A 
chain  LDHA_MOUSE 23 2.62 
P20029 
78 kDa glucose-regulated 
protein  GRP78_MOUSE 39 2.61 
P10126 Elongation factor 1-alpha 1  EF1A1_MOUSE 23 2.54 
Q60605 Myosin light polypeptide 6  MYL6_MOUSE 11 2.51 
Q62159 
Rho-related GTP-binding 
protein RhoC  RHOC_MOUSE 11 2.5 
Q9D1G1 Ras-related protein Rab-1B  RAB1B_MOUSE 17 2.5 
P07901 
Heat shock protein HSP 
90-alpha  HS90A_MOUSE 39 2.47 
P10605 Cathepsin B  CATB_MOUSE 15 2.47 
P68040 
Guanine nucleotide-binding 
protein subunit beta-2-like 
1  GBLP_MOUSE 22 2.47 
P97429 Annexin A4  ANXA4_MOUSE 22 2.4 
Q64669 
NAD(P)H dehydrogenase 
[quinone] 1  NQO1_MOUSE 15 2.38 
O54974 Galectin-7  LEG7_MOUSE 10 2.33 
P33267 Cytochrome P450 2F2  CP2F2_MOUSE 29 2.3 
P47739 
Aldehyde dehydrogenase, 
dimeric NADP-preferring  AL3A1_MOUSE 25 2.29 
Q61508 
Extracellular matrix protein 
1  ECM1_MOUSE 37 2.29 
Q9R0P3 
S-formylglutathione 
hydrolase  ESTD_MOUSE 16 2.28 
P47738 
Aldehyde dehydrogenase, 
mitochondrial  ALDH2_MOUSE 26 2.24 
P17751 
Triosephosphate 
isomerase  TPIS_MOUSE 18 2.19 
P63038 
60 kDa heat shock protein, 
mitochondrial  CH60_MOUSE 36 2.16 
Q61362 Chitinase-3-like protein 1  CH3L1_MOUSE 22 2.16 
P25785 
Metalloproteinase inhibitor 
2  TIMP2_MOUSE 14 2.08 
Q8BFZ3 Beta-actin-like protein 2  ACTBL_MOUSE 24 2.08 
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 Q9DCW4 
Electron transfer 
flavoprotein subunit beta  ETFB_MOUSE 14 2.08 
P63101 14-3-3 protein zeta/delta  1433Z_MOUSE 19 2.07 
Q03265 
ATP synthase subunit 
alpha, mitochondrial  ATPA_MOUSE 36 2.07 
Q62266 Cornifin-A  SPR1A_MOUSE 13 2.01 
P21956 Lactadherin  MFGM_MOUSE 23 1.99 
P15626 
Glutathione S-transferase 
Mu 2  GSTM2_MOUSE 18 1.97 
Q9CQV3 Serpin B11  SPB11_MOUSE 24 1.97 
P63242 
Eukaryotic translation 
initiation factor 5A-1  IF5A1_MOUSE 8 1.93 
P11276 Fibronectin  FINC_MOUSE 108 1.84 
P51881 ADP/ATP translocase 2  ADT2_MOUSE 21 1.84 
P05064 
Fructose-bisphosphate 
aldolase A  ALDOA_MOUSE 23 1.82 
Q01853 
Transitional endoplasmic 
reticulum ATPase  TERA_MOUSE 45 1.82 
P70296 
Phosphatidylethanolamine-
binding protein 1  PEBP1_MOUSE 9 1.81 
P21981 
Protein-glutamine gamma-
glutamyltransferase 2  TGM2_MOUSE 36 1.79 
P26043 Radixin  RADI_MOUSE 39 1.79 
P62245 
40S ribosomal protein 
S15a  RS15A_MOUSE 11 1.76 
Q6IFX2 
Keratin, type I cytoskeletal 
42  K1C42_MOUSE 33 1.75 
Q9DCD0 
6-phosphogluconate 
dehydrogenase, 
decarboxylating  6PGD_MOUSE 29 1.74 
P54116 
Erythrocyte band 7 integral 
membrane protein  STOM_MOUSE 17 1.71 
P26041 Moesin  MOES_MOUSE 40 1.7 
P18242 Cathepsin D  CATD_MOUSE 20 1.67 
Q923D2 Flavin reductase (NADPH)  BLVRB_MOUSE 13 1.65 
Q9R0Q7 Prostaglandin E synthase 3  TEBP_MOUSE 9 1.65 
P23492 
Purine nucleoside 
phosphorylase  PNPH_MOUSE 19 1.64 
Q60932 
Voltage-dependent anion-
selective channel protein 1  VDAC1_MOUSE 18 1.64 
Q9D051 
Pyruvate dehydrogenase 
E1 component subunit 
beta, mitochondrial  ODPB_MOUSE 18 1.63 
Q9WVA4 Transgelin-2  TAGL2_MOUSE 14 1.63 
P37040 
NADPH--cytochrome P450 
reductase  NCPR_MOUSE 35 1.6 
P61027 Ras-related protein Rab-10  RAB10_MOUSE 17 1.6 
P67778 Prohibitin  PHB_MOUSE 18 1.58 
P56382 
ATP synthase subunit 
epsilon, mitochondrial  ATP5E_MOUSE 4 1.56 
O88312 
Anterior gradient protein 2 
homolog  AGR2_MOUSE 10 1.53 
P24369 
Peptidyl-prolyl cis-trans 
isomerase B  PPIB_MOUSE 15 1.51 
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 P50404 
Pulmonary surfactant-
associated protein D  SFTPD_MOUSE 23 1.5 
P48678 Prelamin-A/C  LMNA_MOUSE 46 1.47 
P61750 ADP-ribosylation factor 4  ARF4_MOUSE 12 1.47 
Q61176 Arginase-1  ARGI1_MOUSE 18 1.47 
Q8BSL7 ADP-ribosylation factor 2  ARF2_MOUSE 12 1.45 
P62827 
GTP-binding nuclear 
protein Ran  RAN_MOUSE 11 1.44 
P10810 
Monocyte differentiation 
antigen CD14  CD14_MOUSE 16 1.41 
Q9CRB3 
5-hydroxyisourate 
hydrolase  HIUH_MOUSE 7 1.41 
Q61598 
Rab GDP dissociation 
inhibitor beta  GDIB_MOUSE 28 1.4 
P24549 Retinal dehydrogenase 1  AL1A1_MOUSE 23 1.39 
P38647 
Stress-70 protein, 
mitochondrial  GRP75_MOUSE 43 1.39 
Q61468 Mesothelin  MSLN_MOUSE 29 1.38 
Q9QYB1 
Chloride intracellular 
channel protein 4  CLIC4_MOUSE 17 1.38 
P24472 
Glutathione S-transferase 
A4  GSTA4_MOUSE 12 1.36 
Q8BFU2 Histone H2A type 3  H2A3_MOUSE 7 1.36 
O35129 Prohibitin-2  PHB2_MOUSE 26 1.35 
O88569 
Heterogeneous nuclear 
ribonucleoproteins A2/B1  ROA2_MOUSE 19 1.33 
P47911 60S ribosomal protein L6  RL6_MOUSE 19 1.33 
Q9CPV4 
Glyoxalase domain-
containing protein 4  GLOD4_MOUSE 22 1.33 
Q9WV54 Acid ceramidase  ASAH1_MOUSE 21 1.33 
Q8BPB5 
EGF-containing fibulin-like 
extracellular matrix protein 
1  FBLN3_MOUSE 27 1.31 
Q8VDN2 
Sodium/potassium-
transporting ATPase 
subunit alpha-1  AT1A1_MOUSE 53 1.27 
P97461 40S ribosomal protein S5  RS5_MOUSE 10 1.25 
Q60931 
Voltage-dependent anion-
selective channel protein 3  VDAC3_MOUSE 17 1.25 
Q64433 
10 kDa heat shock protein, 
mitochondrial  CH10_MOUSE 10 1.25 
Q62426 Cystatin-B  CYTB_MOUSE 6 1.24 
Q99LC5 
Electron transfer 
flavoprotein subunit alpha, 
mitochondrial  ETFA_MOUSE 23 1.24 
P47757 
F-actin-capping protein 
subunit beta  CAPZB_MOUSE 20 1.22 
P51174 
Long-chain specific acyl-
CoA dehydrogenase, 
mitochondrial  ACADL_MOUSE 24 1.21 
P08207 Protein S100-A10  S10AA_MOUSE 5 1.2 
P84228 Histone H3.2  H32_MOUSE 6 1.2 
Q9CR57 60S ribosomal protein L14  RL14_MOUSE 12 1.2 
P09411 Phosphoglycerate kinase 1  PGK1_MOUSE 29 1.18 
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 Q6IFZ6 
Keratin, type II cytoskeletal 
1b  K2C1B_MOUSE 39 1.18 
P62267 40S ribosomal protein S23  RS23_MOUSE 8 1.15 
Q91VR2 
ATP synthase subunit 
gamma, mitochondrial  ATPG_MOUSE 17 1.15 
Q9CQI6 Coactosin-like protein  COTL1_MOUSE 10 1.14 
Q9D8N0 Elongation factor 1-gamma  EF1G_MOUSE 27 1.14 
P10639 Thioredoxin  THIO_MOUSE 7 1.12 
P84084 ADP-ribosylation factor 5  ARF5_MOUSE 13 1.12 
P62264 40S ribosomal protein S14  RS14_MOUSE 6 1.11 
Q9ER10 
Brain-specific serine 
protease 4  BSSP4_MOUSE 15 1.11 
Q91VI7 Ribonuclease inhibitor  RINI_MOUSE 27 1.1 
P62702 
40S ribosomal protein S4, 
X isoform  RS4X_MOUSE 20 1.09 
P62717 60S ribosomal protein L18a  RL18A_MOUSE 14 1.09 
P97351 40S ribosomal protein S3a  RS3A_MOUSE 19 1.08 
Q99JY9 Actin-related protein 3  ARP3_MOUSE 21 1.08 
P17879 
Heat shock 70 kDa protein 
1B  HS71B_MOUSE 37 1.07 
P60766 
Cell division control protein 
42 homolog  CDC42_MOUSE 9 1.06 
O88342 
WD repeat-containing 
protein 1  WDR1_MOUSE 37 1.05 
P08905 Lysozyme C-2  LYZ2_MOUSE 10 1.05 
P29758 
Ornithine 
aminotransferase, 
mitochondrial  OAT_MOUSE 23 1.05 
P15532 
Nucleoside diphosphate 
kinase A  NDKA_MOUSE 12 1.03 
P48036 Annexin A5  ANXA5_MOUSE 25 1.03 
P51410 60S ribosomal protein L9  RL9_MOUSE 11 1.03 
Q61171 Peroxiredoxin-2  PRDX2_MOUSE 10 1.03 
Q01768 
Nucleoside diphosphate 
kinase B  NDKB_MOUSE 12 1.02 
Q8K354 
Carbonyl reductase 
[NADPH] 3  CBR3_MOUSE 20 1.02 
Q91XV3 Brain acid soluble protein 1  BASP1_MOUSE 10 1.02 
P62889 60S ribosomal protein L30  RL30_MOUSE 8 1.01 
P99029 
Peroxiredoxin-5, 
mitochondrial  PRDX5_MOUSE 15 1.01 
Q00612 
Glucose-6-phosphate 1-
dehydrogenase X  G6PD1_MOUSE 35 1.01 
P14152 
Malate dehydrogenase, 
cytoplasmic  MDHC_MOUSE 21 1 
Q68FD5 Clathrin heavy chain 1  CLH1_MOUSE 95 0.99 
Q6ZWN5 40S ribosomal protein S9  RS9_MOUSE 14 0.99 
P60843 
Eukaryotic initiation factor 
4A-I  IF4A1_MOUSE 23 0.98 
Q60930 
Voltage-dependent anion-
selective channel protein 2  VDAC2_MOUSE 16 0.98 
Q9WV32 
Actin-related protein 2/3 
complex subunit 1B  ARC1B_MOUSE 19 0.98 
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 P16110 Galectin-3  LEG3_MOUSE 10 0.97 
P35441 Thrombospondin-1  TSP1_MOUSE 70 0.97 
P05202 
Aspartate 
aminotransferase, 
mitochondrial  AATM_MOUSE 29 0.95 
P48962 ADP/ATP translocase 1  ADT1_MOUSE 22 0.95 
P58252 Elongation factor 2  EF2_MOUSE 52 0.95 
P62281 40S ribosomal protein S11  RS11_MOUSE 10 0.94 
P62874 
Guanine nucleotide-binding 
protein G(I)/G(S)/G(T) 
subunit beta-1  GBB1_MOUSE 13 0.94 
Q9WTY4 Aquaporin-5  AQP5_MOUSE 8 0.94 
Q9Z0K8 Pantetheinase  VNN1_MOUSE 23 0.94 
O70435 
Proteasome subunit alpha 
type-3  PSA3_MOUSE 14 0.93 
P53994 Ras-related protein Rab-2A  RAB2A_MOUSE 15 0.93 
Q3UV17 
Keratin, type II cytoskeletal 
2 oral  K22O_MOUSE 39 0.93 
P35486 
Pyruvate dehydrogenase 
E1 component subunit 
alpha, somatic form, 
mitochondrial  ODPA_MOUSE 25 0.92 
P47791 
Glutathione reductase, 
mitochondrial  GSHR_MOUSE 25 0.91 
Q9DAU7 
WAP four-disulfide core 
domain protein 2  WFDC2_MOUSE 6 0.91 
P24452 
Macrophage-capping 
protein  CAPG_MOUSE 14 0.9 
P62259 14-3-3 protein epsilon  1433E_MOUSE 18 0.9 
Q9CZM2 60S ribosomal protein L15  RL15_MOUSE 14 0.9 
P11214 
Tissue-type plasminogen 
activator  TPA_MOUSE 31 0.89 
P62242 40S ribosomal protein S8  RS8_MOUSE 10 0.89 
Q8BG05 
Heterogeneous nuclear 
ribonucleoprotein A3  ROA3_MOUSE 20 0.89 
Q9WUU7 Cathepsin Z  CATZ_MOUSE 14 0.89 
P04104 
Keratin, type II cytoskeletal 
1  K2C1_MOUSE 35 0.88 
Q61581 
Insulin-like growth factor-
binding protein 7  IBP7_MOUSE 18 0.88 
P08113 Endoplasmin  ENPL_MOUSE 47 0.87 
Q3THE2 
Myosin regulatory light 
chain 12B  ML12B_MOUSE 11 0.86 
Q6ZWV3 60S ribosomal protein L10  RL10_MOUSE 13 0.86 
P27659 60S ribosomal protein L3  RL3_MOUSE 22 0.85 
P62331 ADP-ribosylation factor 6  ARF6_MOUSE 9 0.85 
P63323 40S ribosomal protein S12  RS12_MOUSE 7 0.85 
P67984 60S ribosomal protein L22  RL22_MOUSE 6 0.85 
Q80X90 Filamin-B  FLNB_MOUSE 146 0.85 
Q99LX0 Protein DJ-1  PARK7_MOUSE 13 0.85 
P06745 
Glucose-6-phosphate 
isomerase  G6PI_MOUSE 32 0.84 
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 P16460 Argininosuccinate synthase  ASSY_MOUSE 25 0.84 
P48758 
Carbonyl reductase 
[NADPH] 1  CBR1_MOUSE 19 0.84 
Q6ZWU9 40S ribosomal protein S27  RS27_MOUSE 5 0.83 
Q91YQ5 
Dolichyl-
diphosphooligosaccharide--
protein glycosyltransferase 
subunit 1  RPN1_MOUSE 40 0.83 
Q9CXW4 60S ribosomal protein L11  RL11_MOUSE 9 0.83 
O35640 Annexin A8  ANXA8_MOUSE 23 0.82 
P56395 Cytochrome b5  CYB5_MOUSE 8 0.82 
Q9CZ13 
Cytochrome b-c1 complex 
subunit 1, mitochondrial  QCR1_MOUSE 22 0.82 
O88593 
Peptidoglycan recognition 
protein 1  PGRP1_MOUSE 10 0.81 
Q60854 Serpin B6  SPB6_MOUSE 23 0.81 
P14069 Protein S100-A6  S10A6_MOUSE 5 0.79 
P61358 60S ribosomal protein L27  RL27_MOUSE 6 0.79 
P62835 Ras-related protein Rap-1A  RAP1A_MOUSE 10 0.79 
P62880 
Guanine nucleotide-binding 
protein G(I)/G(S)/G(T) 
subunit beta-2  GBB2_MOUSE 13 0.79 
Q9QXC1 Fetuin-B  FETUB_MOUSE 17 0.79 
P11983 
T-complex protein 1 
subunit alpha  TCPA_MOUSE 35 0.78 
P14206 40S ribosomal protein SA  RSSA_MOUSE 15 0.78 
P62137 
Serine/threonine-protein 
phosphatase PP1-alpha 
catalytic subunit  PP1A_MOUSE 19 0.78 
P62911 60S ribosomal protein L32  RL32_MOUSE 8 0.77 
P70441 
Na(+)/H(+) exchange 
regulatory cofactor NHE-
RF1  NHRF1_MOUSE 27 0.77 
P61514 60S ribosomal protein L37a  RL37A_MOUSE 6 0.75 
P61979 
Heterogeneous nuclear 
ribonucleoprotein K  HNRPK_MOUSE 27 0.75 
P63168 
Dynein light chain 1, 
cytoplasmic  DYL1_MOUSE 5 0.75 
P68254 14-3-3 protein theta  1433T_MOUSE 18 0.75 
P0CG49 Polyubiquitin-B  UBB_MOUSE 28 0.74 
P40124 
Adenylyl cyclase-
associated protein 1  CAP1_MOUSE 30 0.74 
P62196 
26S protease regulatory 
subunit 8  PRS8_MOUSE 28 0.74 
Q9CQV8 14-3-3 protein beta/alpha  1433B_MOUSE 17 0.74 
Q9Z2X1 
Heterogeneous nuclear 
ribonucleoprotein F  HNRPF_MOUSE 22 0.74 
O55234 
Proteasome subunit beta 
type-5  PSB5_MOUSE 16 0.73 
P10630 
Eukaryotic initiation factor 
4A-II  IF4A2_MOUSE 23 0.73 
P47962 60S ribosomal protein L5  RL5_MOUSE 17 0.73 
P08752 
Guanine nucleotide-binding 
protein G(i) subunit alpha-2  GNAI2_MOUSE 20 0.72 
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 Q9CQQ7 
ATP synthase F(0) 
complex subunit B1, 
mitochondrial  AT5F1_MOUSE 18 0.72 
Q9DBH5 
Vesicular integral-
membrane protein VIP36  LMAN2_MOUSE 21 0.72 
P14602 Heat shock protein beta-1  HSPB1_MOUSE 12 0.71 
P99026 
Proteasome subunit beta 
type-4  PSB4_MOUSE 11 0.71 
P80316 
T-complex protein 1 
subunit epsilon  TCPE_MOUSE 36 0.7 
P12970 60S ribosomal protein L7a  RL7A_MOUSE 16 0.69 
P51150 Ras-related protein Rab-7a  RAB7A_MOUSE 17 0.69 
P63330 
Serine/threonine-protein 
phosphatase 2A catalytic 
subunit alpha isoform  PP2AA_MOUSE 18 0.69 
P97494 
Glutamate--cysteine ligase 
catalytic subunit  GSH1_MOUSE 34 0.69 
Q8BTM8 Filamin-A  FLNA_MOUSE 143 0.69 
Q99KI0 
Aconitate hydratase, 
mitochondrial  ACON_MOUSE 41 0.69 
O54734 
Dolichyl-
diphosphooligosaccharide--
protein glycosyltransferase 
48 kDa subunit  OST48_MOUSE 22 0.68 
O70570 
Polymeric immunoglobulin 
receptor  PIGR_MOUSE 38 0.68 
P47955 
60S acidic ribosomal 
protein P1  RLA1_MOUSE 4 0.68 
Q8BP67 60S ribosomal protein L24  RL24_MOUSE 10 0.68 
Q91V41 Ras-related protein Rab-14  RAB14_MOUSE 15 0.68 
Q9D154 
Leukocyte elastase 
inhibitor A  ILEUA_MOUSE 23 0.68 
Q9JII6 
Alcohol dehydrogenase 
[NADP(+)]  AK1A1_MOUSE 23 0.68 
P60122 RuvB-like 1  RUVB1_MOUSE 22 0.66 
Q93092 Transaldolase  TALDO_MOUSE 23 0.66 
Q99020 
Heterogeneous nuclear 
ribonucleoprotein A/B  ROAA_MOUSE 14 0.66 
Q9D2Q8 Protein S100-A14  S10AE_MOUSE 8 0.66 
P09405 Nucleolin  NUCL_MOUSE 48 0.65 
P25444 40S ribosomal protein S2  RS2_MOUSE 22 0.65 
Q61503 5~-nucleotidase  5NTD_MOUSE 32 0.65 
Q6IME9 
Keratin, type II cytoskeletal 
72  K2C72_MOUSE 34 0.65 
Q9D1D4 
Transmembrane emp24 
domain-containing protein 
10  TMEDA_MOUSE 10 0.65 
P30115 
Glutathione S-transferase 
A3  GSTA3_MOUSE 14 0.64 
P54071 
Isocitrate dehydrogenase 
[NADP], mitochondrial  IDHP_MOUSE 31 0.64 
P80317 
T-complex protein 1 
subunit zeta  TCPZ_MOUSE 29 0.64 
Q64727 Vinculin  VINC_MOUSE 84 0.64 
Q9WTM5 RuvB-like 2  RUVB2_MOUSE 28 0.64 
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 Q9CZU6 
Citrate synthase, 
mitochondrial  CISY_MOUSE 21 0.63 
P00405 
Cytochrome c oxidase 
subunit 2  COX2_MOUSE 6 0.62 
Q61937 Nucleophosmin  NPM_MOUSE 16 0.62 
Q62186 
Translocon-associated 
protein subunit delta  SSRD_MOUSE 8 0.62 
Q69ZN7 Myoferlin  MYOF_MOUSE 131 0.62 
O55142 60S ribosomal protein L35a  RL35A_MOUSE 9 0.61 
P21107 Tropomyosin alpha-3 chain  TPM3_MOUSE 24 0.61 
P34884 
Macrophage migration 
inhibitory factor  MIF_MOUSE 5 0.61 
Q8VEM8 
Phosphate carrier protein, 
mitochondrial  MPCP_MOUSE 21 0.61 
Q9Z2U1 
Proteasome subunit alpha 
type-5  PSA5_MOUSE 11 0.6 
Q8BMS1 
Trifunctional enzyme 
subunit alpha, 
mitochondrial  ECHA_MOUSE 40 0.59 
O08756 
3-hydroxyacyl-CoA 
dehydrogenase type-2  HCD2_MOUSE 16 0.58 
P35550 
rRNA 2~-O-
methyltransferase fibrillarin  FBRL_MOUSE 24 0.58 
P49312 
Heterogeneous nuclear 
ribonucleoprotein A1  ROA1_MOUSE 19 0.58 
O35737 
Heterogeneous nuclear 
ribonucleoprotein H  HNRH1_MOUSE 25 0.57 
O70456 14-3-3 protein sigma  1433S_MOUSE 19 0.57 
P60867 40S ribosomal protein S20  RS20_MOUSE 6 0.57 
P62315 
Small nuclear 
ribonucleoprotein Sm D1  SMD1_MOUSE 5 0.57 
P62855 40S ribosomal protein S26  RS26_MOUSE 6 0.57 
Q9QUM9 
Proteasome subunit alpha 
type-6  PSA6_MOUSE 13 0.57 
P08003 
Protein disulfide-isomerase 
A4  PDIA4_MOUSE 43 0.56 
P0C0S6 Histone H2A.Z  H2AZ_MOUSE 6 0.56 
P61982 14-3-3 protein gamma  1433G_MOUSE 18 0.56 
P68510 14-3-3 protein eta  1433F_MOUSE 18 0.56 
Q8BP47 
Asparagine--tRNA ligase, 
cytoplasmic  SYNC_MOUSE 30 0.56 
Q9JM76 
Actin-related protein 2/3 
complex subunit 3  ARPC3_MOUSE 12 0.56 
P45376 Aldose reductase  ALDR_MOUSE 20 0.55 
P50396 
Rab GDP dissociation 
inhibitor alpha  GDIA_MOUSE 26 0.55 
P62754 40S ribosomal protein S6  RS6_MOUSE 13 0.55 
P62852 40S ribosomal protein S25  RS25_MOUSE 6 0.55 
Q78IK2 
Up-regulated during 
skeletal muscle growth 
protein 5  USMG5_MOUSE 3 0.55 
P12265 Beta-glucuronidase  BGLR_MOUSE 33 0.54 
P35980 60S ribosomal protein L18  RL18_MOUSE 9 0.54 
P50580 Proliferation-associated PA2G4_MOUSE 24 0.54 
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Q9R118 Serine protease HTRA1  HTRA1_MOUSE 21 0.54 
O54990 Prominin-1  PROM1_MOUSE 41 0.53 
P09803 Cadherin-1  CADH1_MOUSE 33 0.53 
P63001 
Ras-related C3 botulinum 
toxin substrate 1  RAC1_MOUSE 9 0.53 
Q921F2 
TAR DNA-binding protein 
43  TADBP_MOUSE 17 0.53 
P14685 
26S proteasome non-
ATPase regulatory subunit 
3  PSMD3_MOUSE 39 0.52 
P62082 40S ribosomal protein S7  RS7_MOUSE 11 0.52 
Q8BFZ9 Erlin-2  ERLN2_MOUSE 24 0.52 
Q8BHN3 
Neutral alpha-glucosidase 
AB  GANAB_MOUSE 51 0.52 
Q9D8W5 
26S proteasome non-
ATPase regulatory subunit 
12  PSD12_MOUSE 34 0.52 
O55143 
Sarcoplasmic/endoplasmic 
reticulum calcium ATPase 
2  AT2A2_MOUSE 54 0.51 
Q60668 
Heterogeneous nuclear 
ribonucleoprotein D0  HNRPD_MOUSE 15 0.51 
Q9R0Q3 
Transmembrane emp24 
domain-containing protein 
2  TMED2_MOUSE 11 0.51 
O08807 Peroxiredoxin-4  PRDX4_MOUSE 16 0.5 
P29341 
Polyadenylate-binding 
protein 1  PABP1_MOUSE 38 0.5 
P30412 
Peptidyl-prolyl cis-trans 
isomerase C  PPIC_MOUSE 11 0.5 
Q99K51 Plastin-3  PLST_MOUSE 40 0.5 
Q9CYN9 Renin receptor  RENR_MOUSE 17 0.5 
P12032 
Metalloproteinase inhibitor 
1  TIMP1_MOUSE 12 0.49 
P14148 60S ribosomal protein L7  RL7_MOUSE 18 0.49 
P57776 Elongation factor 1-delta  EF1D_MOUSE 20 0.49 
P97430 Antileukoproteinase  SLPI_MOUSE 11 0.49 
Q99PT1 
Rho GDP-dissociation 
inhibitor 1  GDIR1_MOUSE 14 0.49 
Q9DB20 
ATP synthase subunit O, 
mitochondrial  ATPO_MOUSE 14 0.49 
Q9WU78 
Programmed cell death 6-
interacting protein  PDC6I_MOUSE 52 0.49 
P10493 Nidogen-1  NID1_MOUSE 46 0.48 
P17225 
Polypyrimidine tract-binding 
protein 1  PTBP1_MOUSE 22 0.48 
P28474 
Alcohol dehydrogenase 
class-3  ADHX_MOUSE 20 0.48 
P62814 
V-type proton ATPase 
subunit B, brain isoform  VATB2_MOUSE 29 0.48 
P62849 40S ribosomal protein S24  RS24_MOUSE 7 0.48 
P14733 Lamin-B1  LMNB1_MOUSE 39 0.47 
P41105 60S ribosomal protein L28  RL28_MOUSE 11 0.47 
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 P47963 60S ribosomal protein L13  RL13_MOUSE 14 0.47 
P80315 
T-complex protein 1 
subunit delta  TCPD_MOUSE 37 0.47 
Q8BFR5 
Elongation factor Tu, 
mitochondrial  EFTU_MOUSE 31 0.47 
Q9DC16 
Endoplasmic reticulum-
Golgi intermediate 
compartment protein 1  ERGI1_MOUSE 13 0.47 
O70251 Elongation factor 1-beta  EF1B_MOUSE 14 0.46 
P14824 Annexin A6  ANXA6_MOUSE 49 0.46 
P14131 40S ribosomal protein S16  RS16_MOUSE 12 0.45 
P24270 Catalase  CATA_MOUSE 35 0.45 
P24527 Leukotriene A-4 hydrolase  LKHA4_MOUSE 39 0.45 
P42932 
T-complex protein 1 
subunit theta  TCPQ_MOUSE 39 0.45 
P53026 60S ribosomal protein L10a  RL10A_MOUSE 15 0.45 
Q791V5 
Mitochondrial carrier 
homolog 2  MTCH2_MOUSE 14 0.45 
Q9CQX2 Cytochrome b5 type B  CYB5B_MOUSE 8 0.45 
Q9DBG6 
Dolichyl-
diphosphooligosaccharide--
protein glycosyltransferase 
subunit 2  RPN2_MOUSE 26 0.45 
Q9WTP7 
GTP:AMP 
phosphotransferase AK3, 
mitochondrial  KAD3_MOUSE 19 0.45 
P13745 
Glutathione S-transferase 
A1  GSTA1_MOUSE 14 0.44 
P14869 
60S acidic ribosomal 
protein P0  RLA0_MOUSE 18 0.44 
P49722 
Proteasome subunit alpha 
type-2  PSA2_MOUSE 13 0.44 
P61079 
Ubiquitin-conjugating 
enzyme E2 D3  UB2D3_MOUSE 5 0.44 
Q61206 
Platelet-activating factor 
acetylhydrolase IB subunit 
beta  PA1B2_MOUSE 10 0.44 
Q9CVB6 
Actin-related protein 2/3 
complex subunit 2  ARPC2_MOUSE 22 0.44 
P14094 
Sodium/potassium-
transporting ATPase 
subunit beta-1  AT1B1_MOUSE 16 0.43 
P61089 
Ubiquitin-conjugating 
enzyme E2 N  UBE2N_MOUSE 11 0.43 
P61255 60S ribosomal protein L26  RL26_MOUSE 9 0.43 
P62334 
26S protease regulatory 
subunit 10B  PRS10_MOUSE 27 0.43 
Q8K183 Pyridoxal kinase  PDXK_MOUSE 16 0.43 
Q921H8 
3-ketoacyl-CoA thiolase A, 
peroxisomal  THIKA_MOUSE 22 0.43 
Q9D0S9 
Histidine triad nucleotide-
binding protein 2, 
mitochondrial  HINT2_MOUSE 11 0.43 
P06801 
NADP-dependent malic 
enzyme  MAOX_MOUSE 32 0.42 
P16675 Lysosomal protective PPGB_MOUSE 22 0.42 
Disease Models & Mechanisms 9: doi:10.1242/dmm.026658: Supplementary information
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
 protein  
Q62267 Cornifin-B  SPR1B_MOUSE 15 0.42 
Q8K2B3 
Succinate dehydrogenase 
[ubiquinone] flavoprotein 
subunit, mitochondrial  SDHA_MOUSE 36 0.42 
Q9JJI8 60S ribosomal protein L38  RL38_MOUSE 3 0.42 
P35979 60S ribosomal protein L12  RL12_MOUSE 11 0.41 
P62270 40S ribosomal protein S18  RS18_MOUSE 12 0.41 
Q8R081 
Heterogeneous nuclear 
ribonucleoprotein L  HNRPL_MOUSE 24 0.41 
Q9JJ00 Phospholipid scramblase 1  PLS1_MOUSE 13 0.41 
P45952 
Medium-chain specific acyl-
CoA dehydrogenase, 
mitochondrial  ACADM_MOUSE 22 0.4 
P60335 Poly(rC)-binding protein 1  PCBP1_MOUSE 20 0.4 
P61939 Thyroxine-binding globulin  THBG_MOUSE 22 0.4 
Q08761 
Vitamin K-dependent 
protein S  PROS_MOUSE 37 0.4 
Q61753 
D-3-phosphoglycerate 
dehydrogenase  SERA_MOUSE 22 0.4 
Q9D8E6 60S ribosomal protein L4  RL4_MOUSE 27 0.4 
Q9WV55 
Vesicle-associated 
membrane protein-
associated protein A  VAPA_MOUSE 15 0.4 
Q9Z2U0 
Proteasome subunit alpha 
type-7  PSA7_MOUSE 16 0.4 
O09167 60S ribosomal protein L21  RL21_MOUSE 9 0.39 
P63325 40S ribosomal protein S10  RS10_MOUSE 13 0.39 
Q8VEK3 
Heterogeneous nuclear 
ribonucleoprotein U  HNRPU_MOUSE 43 0.39 
Q922R8 
Protein disulfide-isomerase 
A6  PDIA6_MOUSE 25 0.39 
Q9DB77 
Cytochrome b-c1 complex 
subunit 2, mitochondrial  QCR2_MOUSE 22 0.39 
P13597 
Intercellular adhesion 
molecule 1  ICAM1_MOUSE 26 0.38 
P17710 Hexokinase-1  HXK1_MOUSE 57 0.38 
P70333 
Heterogeneous nuclear 
ribonucleoprotein H2  HNRH2_MOUSE 25 0.38 
Q02053 
Ubiquitin-like modifier-
activating enzyme 1  UBA1_MOUSE 55 0.38 
Q6URW6 Myosin-14  MYH14_MOUSE 126 0.38 
Q9DBJ1 
Phosphoglycerate mutase 
1  PGAM1_MOUSE 15 0.38 
P26443 
Glutamate dehydrogenase 
1, mitochondrial  DHE3_MOUSE 35 0.37 
P48771 
Cytochrome c oxidase 
subunit 7A2, mitochondrial  CX7A2_MOUSE 5 0.37 
P59999 
Actin-related protein 2/3 
complex subunit 4  ARPC4_MOUSE 13 0.37 
P70195 
Proteasome subunit beta 
type-7  PSB7_MOUSE 12 0.37 
Q62425 
Cytochrome c oxidase 
subunit NDUFA4  NDUA4_MOUSE 6 0.37 
Q9D6R2 Isocitrate dehydrogenase IDH3A_MOUSE 21 0.37 
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 [NAD] subunit alpha, 
mitochondrial  
Q9R1P0 
Proteasome subunit alpha 
type-4  PSA4_MOUSE 14 0.37 
O55023 
Inositol monophosphatase 
1  IMPA1_MOUSE 17 0.36 
P42208 Septin-2  SEPT2_MOUSE 21 0.36 
Q8CAQ8 
MICOS complex subunit 
Mic60  MIC60_MOUSE 55 0.36 
Q99JY0 
Trifunctional enzyme 
subunit beta, mitochondrial  ECHB_MOUSE 28 0.36 
P04186 Complement factor B  CFAB_MOUSE 42 0.35 
P13020 Gelsolin  GELS_MOUSE 34 0.35 
P25085 
Interleukin-1 receptor 
antagonist protein  IL1RA_MOUSE 7 0.35 
P61211 
ADP-ribosylation factor-like 
protein 1  ARL1_MOUSE 10 0.35 
P70124 Serpin B5  SPB5_MOUSE 22 0.35 
Q9QZ88 
Vacuolar protein sorting-
associated protein 29  VPS29_MOUSE 11 0.35 
O08749 
Dihydrolipoyl 
dehydrogenase, 
mitochondrial  DLDH_MOUSE 26 0.34 
P47740 
Fatty aldehyde 
dehydrogenase  AL3A2_MOUSE 21 0.34 
P97384 Annexin A11  ANX11_MOUSE 22 0.34 
P97449 Aminopeptidase N  AMPN_MOUSE 51 0.34 
P97807 
Fumarate hydratase, 
mitochondrial  FUMH_MOUSE 32 0.34 
Q62465 
Synaptic vesicle membrane 
protein VAT-1 homolog  VAT1_MOUSE 18 0.34 
Q99K48 
Non-POU domain-
containing octamer-binding 
protein  NONO_MOUSE 23 0.34 
Q9CQS8 
Protein transport protein 
Sec61 subunit beta  SC61B_MOUSE 6 0.34 
Q9DC53 Copine-8  CPNE8_MOUSE 33 0.34 
Q9JKR6 
Hypoxia up-regulated 
protein 1  HYOU1_MOUSE 58 0.34 
O55022 
Membrane-associated 
progesterone receptor 
component 1  PGRC1_MOUSE 10 0.33 
Q07813 Apoptosis regulator BAX  BAX_MOUSE 10 0.33 
Q9CQW2 
ADP-ribosylation factor-like 
protein 8B  ARL8B_MOUSE 12 0.33 
Q9DBS1 Transmembrane protein 43  TMM43_MOUSE 21 0.33 
P36536 
GTP-binding protein 
SAR1a  SAR1A_MOUSE 11 0.32 
P46978 
Dolichyl-
diphosphooligosaccharide--
protein glycosyltransferase 
subunit STT3A  STT3A_MOUSE 36 0.32 
P80314 
T-complex protein 1 
subunit beta  TCPB_MOUSE 36 0.32 
Q7TMK9 
Heterogeneous nuclear 
ribonucleoprotein Q  HNRPQ_MOUSE 39 0.32 
Disease Models & Mechanisms 9: doi:10.1242/dmm.026658: Supplementary information
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
 Q8BMF4 
Dihydrolipoyllysine-residue 
acetyltransferase 
component of pyruvate 
dehydrogenase complex, 
mitochondrial  ODP2_MOUSE 33 0.32 
Q8JZU2 
Tricarboxylate transport 
protein, mitochondrial  TXTP_MOUSE 17 0.32 
Q922B2 
Aspartate--tRNA ligase, 
cytoplasmic  SYDC_MOUSE 38 0.32 
Q9CQN1 
Heat shock protein 75 kDa, 
mitochondrial  TRAP1_MOUSE 50 0.32 
Q9DCN2 
NADH-cytochrome b5 
reductase 3  NB5R3_MOUSE 17 0.32 
O70503 
Estradiol 17-beta-
dehydrogenase 12  DHB12_MOUSE 18 0.31 
O88310 Intelectin-1a  ITL1A_MOUSE 17 0.31 
P05201 
Aspartate 
aminotransferase, 
cytoplasmic  AATC_MOUSE 27 0.31 
P42669 
Transcriptional activator 
protein Pur-alpha  PURA_MOUSE 15 0.31 
P62305 
Small nuclear 
ribonucleoprotein E  RUXE_MOUSE 4 0.31 
Q02257 Junction plakoglobin  PLAK_MOUSE 44 0.31 
Q9D1Q6 
Endoplasmic reticulum 
resident protein 44  ERP44_MOUSE 24 0.31 
Q9JKF1 
Ras GTPase-activating-like 
protein IQGAP1  IQGA1_MOUSE 93 0.31 
Q9QWR8 
Alpha-N-
acetylgalactosaminidase  NAGAB_MOUSE 27 0.31 
Q9R1P1 
Proteasome subunit beta 
type-3  PSB3_MOUSE 9 0.31 
P19253 60S ribosomal protein L13a  RL13A_MOUSE 17 0.3 
P27048 
Small nuclear 
ribonucleoprotein-
associated protein B  RSMB_MOUSE 14 0.3 
P35279 Ras-related protein Rab-6A  RAB6A_MOUSE 17 0.3 
P80313 
T-complex protein 1 
subunit eta  TCPH_MOUSE 33 0.3 
P80318 
T-complex protein 1 
subunit gamma  TCPG_MOUSE 38 0.3 
P97467 
Peptidyl-glycine alpha-
amidating monooxygenase  AMD_MOUSE 51 0.3 
Q62167 
ATP-dependent RNA 
helicase DDX3X  DDX3X_MOUSE 40 0.3 
Q8K3J9 
G-protein coupled receptor 
family C group 5 member C  GPC5C_MOUSE 11 0.3 
Q9CQD1 Ras-related protein Rab-5A  RAB5A_MOUSE 14 0.3 
Q9ESW8 Pyroglutamyl-peptidase 1  PGPI_MOUSE 10 0.3 
Q9JIW9 Ras-related protein Ral-B  RALB_MOUSE 10 0.3 
Q9WUM5 
Succinyl-CoA ligase 
[ADP/GDP-forming] subunit 
alpha, mitochondrial  SUCA_MOUSE 15 0.3 
Q9Z0L8 Gamma-glutamyl hydrolase  GGH_MOUSE 17 0.3 
O08547 
Vesicle-trafficking protein 
SEC22b  SC22B_MOUSE 13 0.29 
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 O70554 
Small proline-rich protein 
2B  SPR2B_MOUSE 5 0.29 
P00493 
Hypoxanthine-guanine 
phosphoribosyltransferase  HPRT_MOUSE 13 0.29 
P46638 
Ras-related protein Rab-
11B  RB11B_MOUSE 16 0.29 
Q07076 Annexin A7  ANXA7_MOUSE 23 0.29 
Q61879 Myosin-10  MYH10_MOUSE 125 0.29 
Q8K353 
Cysteine-rich and 
transmembrane domain-
containing protein 1  CYTM1_MOUSE 2 0.29 
Q8VDW0 
ATP-dependent RNA 
helicase DDX39A  DX39A_MOUSE 26 0.29 
Q9CYH2 
Redox-regulatory protein 
FAM213A  F213A_MOUSE 14 0.29 
Q9D103 
Interferon-induced 
transmembrane protein 1  IFM1_MOUSE 2 0.29 
Q9R112 
Sulfide:quinone 
oxidoreductase, 
mitochondrial  SQRD_MOUSE 32 0.29 
O54782 
Epididymis-specific alpha-
mannosidase  MA2B2_MOUSE 44 0.28 
P30416 
Peptidyl-prolyl cis-trans 
isomerase FKBP4  FKBP4_MOUSE 30 0.28 
P47964 60S ribosomal protein L36  RL36_MOUSE 7 0.28 
P63158 
High mobility group protein 
B1  HMGB1_MOUSE 11 0.28 
Q3UQ28 Peroxidasin homolog  PXDN_MOUSE 86 0.28 
Q60692 
Proteasome subunit beta 
type-6  PSB6_MOUSE 11 0.28 
Q62093 
Serine/arginine-rich splicing 
factor 2  SRSF2_MOUSE 11 0.28 
Q6IRU5 Clathrin light chain B  CLCB_MOUSE 10 0.28 
Q78IS1 
Transmembrane emp24 
domain-containing protein 
3  TMED3_MOUSE 13 0.28 
Q91WS0 
CDGSH iron-sulfur domain-
containing protein 1  CISD1_MOUSE 6 0.28 
Q9CWJ9 
Bifunctional purine 
biosynthesis protein PURH  PUR9_MOUSE 35 0.28 
Q9ERI2 
Ras-related protein Rab-
27A  RB27A_MOUSE 13 0.28 
Q9WVJ9 
EGF-containing fibulin-like 
extracellular matrix protein 
2  FBLN4_MOUSE 23 0.28 
O09061 
Proteasome subunit beta 
type-1  PSB1_MOUSE 14 0.27 
P51807 
Dynein light chain Tctex-
type 1  DYLT1_MOUSE 7 0.27 
P61804 
Dolichyl-
diphosphooligosaccharide--
protein glycosyltransferase 
subunit DAD1  DAD1_MOUSE 5 0.27 
P83882 60S ribosomal protein L36a  RL36A_MOUSE 6 0.27 
Q8R3G9 Tetraspanin-8  TSN8_MOUSE 8 0.27 
Q91X52 L-xylulose reductase  DCXR_MOUSE 15 0.27 
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 Q9WUA2 
Phenylalanine--tRNA ligase 
beta subunit  SYFB_MOUSE 41 0.27 
Q9Z2W0 Aspartyl aminopeptidase  DNPEP_MOUSE 24 0.27 
O35215 
D-dopachrome 
decarboxylase  DOPD_MOUSE 9 0.26 
P62869 
Transcription elongation 
factor B polypeptide 2  ELOB_MOUSE 9 0.26 
Q61656 
Probable ATP-dependent 
RNA helicase DDX5  DDX5_MOUSE 35 0.26 
Q64437 
Alcohol dehydrogenase 
class 4 mu/sigma chain  ADH7_MOUSE 23 0.26 
Q6PCW6 Cornifelin  CNFN_MOUSE 2 0.26 
Q8CG76 
Aflatoxin B1 aldehyde 
reductase member 2  ARK72_MOUSE 17 0.26 
Q8CI94 
Glycogen phosphorylase, 
brain form  PYGB_MOUSE 53 0.26 
Q91VR5 
ATP-dependent RNA 
helicase DDX1  DDX1_MOUSE 46 0.26 
Q91YD6 Villin-like protein  VILL_MOUSE 51 0.26 
Q9D8Y0 
EF-hand domain-containing 
protein D2  EFHD2_MOUSE 16 0.26 
P12023 Amyloid beta A4 protein  A4_MOUSE 39 0.25 
P20108 
Thioredoxin-dependent 
peroxide reductase, 
mitochondrial  PRDX3_MOUSE 15 0.25 
P46735 Unconventional myosin-Ib  MYO1B_MOUSE 70 0.25 
Q02248 Catenin beta-1  CTNB1_MOUSE 42 0.25 
Q571E4 
N-acetylgalactosamine-6-
sulfatase  GALNS_MOUSE 25 0.25 
Q8BK67 Protein RCC2  RCC2_MOUSE 32 0.25 
Q8K2I4 Beta-mannosidase  MANBA_MOUSE 49 0.25 
Q8VDM4 
26S proteasome non-
ATPase regulatory subunit 
2  PSMD2_MOUSE 56 0.25 
Q91V12 
Cytosolic acyl coenzyme A 
thioester hydrolase  BACH_MOUSE 20 0.25 
Q9D0F3 Protein ERGIC-53  LMAN1_MOUSE 25 0.25 
Q9D1R9 60S ribosomal protein L34  RL34_MOUSE 6 0.25 
Q9JIF0 
Protein arginine N-
methyltransferase 1  ANM1_MOUSE 20 0.25 
P10852 
4F2 cell-surface antigen 
heavy chain  4F2_MOUSE 30 0.24 
P62320 
Small nuclear 
ribonucleoprotein Sm D3  SMD3_MOUSE 9 0.24 
P70349 
Histidine triad nucleotide-
binding protein 1  HINT1_MOUSE 8 0.24 
Q07417 
Short-chain specific acyl-
CoA dehydrogenase, 
mitochondrial  ACADS_MOUSE 21 0.24 
Q61703 
Inter-alpha-trypsin inhibitor 
heavy chain H2  ITIH2_MOUSE 48 0.24 
Q8BKX1 
Brain-specific angiogenesis 
inhibitor 1-associated 
protein 2  BAIP2_MOUSE 42 0.24 
Q8BT60 Copine-3  CPNE3_MOUSE 26 0.24 
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 Q9CQM5 
Thioredoxin domain-
containing protein 17  TXD17_MOUSE 8 0.24 
Q9DCV5 
Transmembrane protein 
254  TM254_MOUSE 4 0.24 
O09172 
Glutamate--cysteine ligase 
regulatory subunit  GSH0_MOUSE 12 0.23 
P23953 Carboxylesterase 1C  EST1C_MOUSE 25 0.23 
P28656 
Nucleosome assembly 
protein 1-like 1  NP1L1_MOUSE 13 0.23 
P62900 60S ribosomal protein L31  RL31_MOUSE 7 0.23 
Q61316 
Heat shock 70 kDa protein 
4  HSP74_MOUSE 57 0.23 
Q64310 Surfeit locus protein 4  SURF4_MOUSE 9 0.23 
Q64435 
UDP-
glucuronosyltransferase 1-
6  UD16_MOUSE 25 0.23 
Q9CX86 
Heterogeneous nuclear 
ribonucleoprotein A0  ROA0_MOUSE 15 0.23 
Q9D0T1 NHP2-like protein 1  NH2L1_MOUSE 9 0.23 
Q9QYJ0 
DnaJ homolog subfamily A 
member 2  DNJA2_MOUSE 23 0.23 
P16045 Galectin-1  LEG1_MOUSE 9 0.22 
P24668 
Cation-dependent 
mannose-6-phosphate 
receptor  MPRD_MOUSE 18 0.22 
P50247 Adenosylhomocysteinase  SAHH_MOUSE 27 0.22 
P63276 40S ribosomal protein S17  RS17_MOUSE 6 0.22 
Q02496 Mucin-1  MUC1_MOUSE 11 0.22 
Q7TQI3 
Ubiquitin thioesterase 
OTUB1  OTUB1_MOUSE 15 0.22 
Q8BH95 
Enoyl-CoA hydratase, 
mitochondrial  ECHM_MOUSE 18 0.22 
Q8VC85 
U6 snRNA-associated Sm-
like protein LSm1  LSM1_MOUSE 11 0.22 
Q99JZ0 Syntenin-2  SDCB2_MOUSE 16 0.22 
Q9CQR4 
Acyl-coenzyme A 
thioesterase 13  ACO13_MOUSE 10 0.22 
Q9CQW9 
Interferon-induced 
transmembrane protein 3  IFM3_MOUSE 4 0.22 
Q9DCL9 
Multifunctional protein 
ADE2  PUR6_MOUSE 27 0.22 
Q9EQK5 Major vault protein  MVP_MOUSE 51 0.22 
Q9EST5 
Acidic leucine-rich nuclear 
phosphoprotein 32 family 
member B  AN32B_MOUSE 12 0.22 
Q9QZD8 
Mitochondrial dicarboxylate 
carrier  DIC_MOUSE 17 0.22 
Q9WUZ9 
Ectonucleoside 
triphosphate 
diphosphohydrolase 5  ENTP5_MOUSE 24 0.22 
O08992 Syntenin-1  SDCB1_MOUSE 15 0.21 
O55131 Septin-7  SEPT7_MOUSE 26 0.21 
O88685 
26S protease regulatory 
subunit 6A  PRS6A_MOUSE 26 0.21 
P10923 Osteopontin  OSTP_MOUSE 12 0.21 
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 P12787 
Cytochrome c oxidase 
subunit 5A, mitochondrial  COX5A_MOUSE 10 0.21 
P16546 
Spectrin alpha chain, non-
erythrocytic 1  SPTN1_MOUSE 189 0.21 
P20352 Tissue factor  TF_MOUSE 17 0.21 
P21460 Cystatin-C  CYTC_MOUSE 10 0.21 
P35564 Calnexin  CALX_MOUSE 27 0.21 
P42125 
Enoyl-CoA delta isomerase 
1, mitochondrial  ECI1_MOUSE 18 0.21 
P47753 
F-actin-capping protein 
subunit alpha-1  CAZA1_MOUSE 17 0.21 
P47754 
F-actin-capping protein 
subunit alpha-2  CAZA2_MOUSE 15 0.21 
P50516 
V-type proton ATPase 
catalytic subunit A  VATA_MOUSE 37 0.21 
P52196 
Thiosulfate 
sulfurtransferase  THTR_MOUSE 18 0.21 
P63082 
V-type proton ATPase 16 
kDa proteolipid subunit  VATL_MOUSE 3 0.21 
Q00915 Retinol-binding protein 1  RET1_MOUSE 12 0.21 
Q60597 
2-oxoglutarate 
dehydrogenase, 
mitochondrial  ODO1_MOUSE 52 0.21 
Q6ZQI3 Malectin  MLEC_MOUSE 18 0.21 
Q8C1B7 Septin-11  SEP11_MOUSE 25 0.21 
Q8R164 Valacyclovir hydrolase  BPHL_MOUSE 23 0.21 
Q99K30 
Epidermal growth factor 
receptor kinase substrate 
8-like protein 2  ES8L2_MOUSE 40 0.21 
Q9D2G2 
Dihydrolipoyllysine-residue 
succinyltransferase 
component of 2-
oxoglutarate 
dehydrogenase complex, 
mitochondrial  ODO2_MOUSE 23 0.21 
Q9EQU5 Protein SET  SET_MOUSE 12 0.21 
Q9R0X4 
Acyl-coenzyme A 
thioesterase 9, 
mitochondrial  ACOT9_MOUSE 30 0.21 
Q9Z2I9 
Succinyl-CoA ligase [ADP-
forming] subunit beta, 
mitochondrial  SUCB1_MOUSE 31 0.21 
P62204 Calmodulin  CALM_MOUSE 9 0.2 
P97326 Cadherin-6  CADH6_MOUSE 40 0.2 
Q02819 Nucleobindin-1  NUCB1_MOUSE 29 0.2 
Q61425 
Hydroxyacyl-coenzyme A 
dehydrogenase, 
mitochondrial  HCDH_MOUSE 19 0.2 
Q7TNG5 
Echinoderm microtubule-
associated protein-like 2  EMAL2_MOUSE 31 0.2 
Q80UW2 F-box only protein 2  FBX2_MOUSE 14 0.2 
Q80VQ0 
Aldehyde dehydrogenase 
family 3 member B1  AL3B1_MOUSE 24 0.2 
Q80Y14 
Glutaredoxin-related 
protein 5, mitochondrial  GLRX5_MOUSE 8 0.2 
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 Q8BMD8 
Calcium-binding 
mitochondrial carrier 
protein SCaMC-1  SCMC1_MOUSE 29 0.2 
Q9ERS2 
NADH dehydrogenase 
[ubiquinone] 1 alpha 
subcomplex subunit 13  NDUAD_MOUSE 10 0.2 
Q9WVJ3 Carboxypeptidase Q  CBPQ_MOUSE 21 0.2 
Q9Z0N1 
Eukaryotic translation 
initiation factor 2 subunit 3, 
X-linked  IF2G_MOUSE 24 0.2 
Q9Z1Q9 Valine--tRNA ligase  SYVC_MOUSE 66 0.2 
P16125 
L-lactate dehydrogenase B 
chain  LDHB_MOUSE 21 0.19 
P27046 Alpha-mannosidase 2  MA2A1_MOUSE 63 0.19 
P70372 ELAV-like protein 1  ELAV1_MOUSE 17 0.19 
Q91VS7 
Microsomal glutathione S-
transferase 1  MGST1_MOUSE 6 0.19 
Q99JW5 
Epithelial cell adhesion 
molecule  EPCAM_MOUSE 14 0.19 
Q9CZ42 
ATP-dependent (S)-
NAD(P)H-hydrate 
dehydratase  NNRD_MOUSE 18 0.19 
Q9D1M0 Protein SEC13 homolog  SEC13_MOUSE 13 0.19 
Q9D3D9 
ATP synthase subunit 
delta, mitochondrial  ATPD_MOUSE 5 0.19 
Q9DAW9 Calponin-3  CNN3_MOUSE 18 0.19 
Q9QZD9 
Eukaryotic translation 
initiation factor 3 subunit I  EIF3I_MOUSE 22 0.19 
O35685 
Nuclear migration protein 
nudC  NUDC_MOUSE 23 0.18 
O70492 Sorting nexin-3  SNX3_MOUSE 10 0.18 
Q61990 Poly(rC)-binding protein 2  PCBP2_MOUSE 18 0.18 
Q7TQ65 
Transmembrane channel-
like protein 4  TMC4_MOUSE 33 0.18 
Q80YX1 Tenascin  TENA_MOUSE 105 0.18 
Q8JZM8 Mucin-4  MUC4_MOUSE 115 0.18 
Q8K023 
Aldo-keto reductase family 
1 member C18  AKC1H_MOUSE 22 0.18 
Q91YW3 
DnaJ homolog subfamily C 
member 3  DNJC3_MOUSE 32 0.18 
Q9CRB6 
Tubulin polymerization-
promoting protein family 
member 3  TPPP3_MOUSE 14 0.18 
Q9D0E1 
Heterogeneous nuclear 
ribonucleoprotein M  HNRPM_MOUSE 52 0.18 
Q9DCX2 
ATP synthase subunit d, 
mitochondrial  ATP5H_MOUSE 11 0.18 
Q9QXD1 
Peroxisomal acyl-
coenzyme A oxidase 2  ACOX2_MOUSE 41 0.18 
Q9QYA2 
Mitochondrial import 
receptor subunit TOM40 
homolog  TOM40_MOUSE 12 0.18 
B2RWJ3 
Transmembrane protein 
240  TM240_MOUSE 6 0.17 
P20060 
Beta-hexosaminidase 
subunit beta  HEXB_MOUSE 30 0.17 
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 P26231 Catenin alpha-1  CTNA1_MOUSE 56 0.17 
P29268 
Connective tissue growth 
factor  CTGF_MOUSE 24 0.17 
P51660 
Peroxisomal multifunctional 
enzyme type 2  DHB4_MOUSE 40 0.17 
P63028 
Translationally-controlled 
tumor protein  TCTP_MOUSE 7 0.17 
P84104 
Serine/arginine-rich splicing 
factor 3  SRSF3_MOUSE 10 0.17 
Q64176 Carboxylesterase 1E  EST1E_MOUSE 26 0.17 
Q8BHL4 
Retinoic acid-induced 
protein 3  RAI3_MOUSE 13 0.17 
Q8BI08 Protein MAL2  MAL2_MOUSE 2 0.17 
Q99K85 
Phosphoserine 
aminotransferase  SERC_MOUSE 27 0.17 
Q99KK7 Dipeptidyl peptidase 3  DPP3_MOUSE 46 0.17 
Q9CX00 IST1 homolog  IST1_MOUSE 12 0.17 
Q9EQP2 
EH domain-containing 
protein 4  EHD4_MOUSE 32 0.17 
Q9QUR6 Prolyl endopeptidase  PPCE_MOUSE 47 0.17 
Q9QZQ8 Core histone macro-H2A.1  H2AY_MOUSE 19 0.17 
P15864 Histone H1.2  H12_MOUSE 12 0.16 
P23198 
Chromobox protein 
homolog 3  CBX3_MOUSE 10 0.16 
P70404 
Isocitrate dehydrogenase 
[NAD] subunit gamma 1, 
mitochondrial  IDHG1_MOUSE 17 0.16 
P97315 
Cysteine and glycine-rich 
protein 1  CSRP1_MOUSE 14 0.16 
Q63844 
Mitogen-activated protein 
kinase 3  MK03_MOUSE 22 0.16 
Q76MZ3 
Serine/threonine-protein 
phosphatase 2A 65 kDa 
regulatory subunit A alpha 
isoform  2AAA_MOUSE 39 0.16 
Q8BMK4 
Cytoskeleton-associated 
protein 4  CKAP4_MOUSE 40 0.16 
Q8BWT1 
3-ketoacyl-CoA thiolase, 
mitochondrial  THIM_MOUSE 24 0.16 
Q8VCC2 Liver carboxylesterase 1  EST1_MOUSE 23 0.16 
Q9R0P6 
Signal peptidase complex 
catalytic subunit SEC11A  SC11A_MOUSE 12 0.16 
Q9R0Q6 
Actin-related protein 2/3 
complex subunit 1A  ARC1A_MOUSE 23 0.16 
O35286 
Putative pre-mRNA-splicing 
factor ATP-dependent RNA 
helicase DHX15  DHX15_MOUSE 43 0.15 
P11438 
Lysosome-associated 
membrane glycoprotein 1  LAMP1_MOUSE 18 0.15 
P12815 
Programmed cell death 
protein 6  PDCD6_MOUSE 10 0.15 
P15535 
Beta-1,4-
galactosyltransferase 1  B4GT1_MOUSE 19 0.15 
P61161 Actin-related protein 2  ARP2_MOUSE 21 0.15 
Q61187 
Tumor susceptibility gene 
101 protein  TS101_MOUSE 18 0.15 
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 Q62261 
Spectrin beta chain, non-
erythrocytic 1  SPTB2_MOUSE 161 0.15 
Q62470 Integrin alpha-3  ITA3_MOUSE 40 0.15 
Q64324 Syntaxin-binding protein 2  STXB2_MOUSE 40 0.15 
Q8K211 
High affinity copper uptake 
protein 1  COPT1_MOUSE 3 0.15 
Q8R2S8 CD177 antigen  CD177_MOUSE 37 0.15 
Q8VCF1 
Soluble calcium-activated 
nucleotidase 1  CANT1_MOUSE 27 0.15 
Q9CZ30 Obg-like ATPase 1  OLA1_MOUSE 26 0.15 
Q9DBP5 UMP-CMP kinase  KCY_MOUSE 11 0.15 
Q9DCS2 
UPF0585 protein C16orf13 
homolog  CP013_MOUSE   0.15 
Q9JHI5 
Isovaleryl-CoA 
dehydrogenase, 
mitochondrial  IVD_MOUSE 24 0.15 
Q9Z0F4 
Calcium and integrin-
binding protein 1  CIB1_MOUSE 15 0.15 
Q9Z261 Claudin-7  CLD7_MOUSE 4 0.15 
O88668 Protein CREG1  CREG1_MOUSE 11 0.14 
P06869 
Urokinase-type 
plasminogen activator  UROK_MOUSE 25 0.14 
P10833 Ras-related protein R-Ras  RRAS_MOUSE 16 0.14 
P28301 Protein-lysine 6-oxidase  LYOX_MOUSE 20 0.14 
P30275 
Creatine kinase U-type, 
mitochondrial  KCRU_MOUSE 26 0.14 
P35282 Ras-related protein Rab-21  RAB21_MOUSE 15 0.14 
P35293 Ras-related protein Rab-18  RAB18_MOUSE 14 0.14 
P45700 
Mannosyl-oligosaccharide 
1,2-alpha-mannosidase IA  MA1A1_MOUSE 37 0.14 
P46467 
Vacuolar protein sorting-
associated protein 4B  VPS4B_MOUSE 27 0.14 
P46471 
26S protease regulatory 
subunit 7  PRS7_MOUSE 31 0.14 
P54775 
26S protease regulatory 
subunit 6B  PRS6B_MOUSE 22 0.14 
P84099 60S ribosomal protein L19  RL19_MOUSE 9 0.14 
Q501J6 
Probable ATP-dependent 
RNA helicase DDX17  DDX17_MOUSE 35 0.14 
Q60963 
Platelet-activating factor 
acetylhydrolase  PAFA_MOUSE 23 0.14 
Q62165 Dystroglycan  DAG1_MOUSE 42 0.14 
Q78IQ7 Zinc transporter ZIP4  S39A4_MOUSE 18 0.14 
Q8BG32 
26S proteasome non-
ATPase regulatory subunit 
11  PSD11_MOUSE 32 0.14 
Q8R2Y2 
Cell surface glycoprotein 
MUC18  MUC18_MOUSE 34 0.14 
Q8VDP6 
CDP-diacylglycerol--inositol 
3-phosphatidyltransferase  CDIPT_MOUSE 10 0.14 
Q8VIJ6 
Splicing factor, proline- and 
glutamine-rich  SFPQ_MOUSE 31 0.14 
Q91VC3 
Eukaryotic initiation factor 
4A-III  IF4A3_MOUSE 25 0.14 
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 Q91W90 
Thioredoxin domain-
containing protein 5  TXND5_MOUSE 23 0.14 
Q99LP6 
GrpE protein homolog 1, 
mitochondrial  GRPE1_MOUSE 17 0.14 
Q9DCT8 Cysteine-rich protein 2  CRIP2_MOUSE 11 0.14 
Q9JM14 
5~(3~)-
deoxyribonucleotidase, 
cytosolic type  NT5C_MOUSE 11 0.14 
Q9WTI7 Unconventional myosin-Ic  MYO1C_MOUSE 66 0.14 
Q9WTL2 Ras-related protein Rab-25  RAB25_MOUSE 14 0.14 
Q9Z2I8 
Succinyl-CoA ligase [GDP-
forming] subunit beta, 
mitochondrial  SUCB2_MOUSE 30 0.14 
P09671 
Superoxide dismutase 
[Mn], mitochondrial  SODM_MOUSE 13 0.13 
P35762 CD81 antigen  CD81_MOUSE 7 0.13 
P40240 CD9 antigen  CD9_MOUSE 6 0.13 
P51855 Glutathione synthetase  GSHB_MOUSE 29 0.13 
P51859 
Hepatoma-derived growth 
factor  HDGF_MOUSE 16 0.13 
P63073 
Eukaryotic translation 
initiation factor 4E  IF4E_MOUSE 14 0.13 
P70202 Latexin  LXN_MOUSE 6 0.13 
Q3TXS7 
26S proteasome non-
ATPase regulatory subunit 
1  PSMD1_MOUSE 50 0.13 
Q61205 
Platelet-activating factor 
acetylhydrolase IB subunit 
gamma  PA1B3_MOUSE 17 0.13 
Q64521 
Glycerol-3-phosphate 
dehydrogenase, 
mitochondrial  GPDM_MOUSE 48 0.13 
Q8BHH8 Clarin-3  CLRN3_MOUSE 6 0.13 
Q8R016 Bleomycin hydrolase  BLMH_MOUSE 28 0.13 
Q8R5F8 
Epidermal growth factor 
receptor kinase substrate 
8-like protein 1  ES8L1_MOUSE 41 0.13 
Q8VCR9 
Occludin/ELL domain-
containing protein 1  OCEL1_MOUSE 14 0.13 
Q8VEN2 
Placenta-expressed 
transcript 1 protein  PLET1_MOUSE 4 0.13 
Q91VT4 
Carbonyl reductase family 
member 4  CBR4_MOUSE 14 0.13 
Q91VU0 Protein FAM3C  FAM3C_MOUSE 16 0.13 
Q99JR5 
Tubulointerstitial nephritis 
antigen-like  TINAL_MOUSE 22 0.13 
Q99LJ1 Tissue alpha-L-fucosidase  FUCO_MOUSE 25 0.13 
Q9D8T0 Protein FAM3A  FAM3A_MOUSE 15 0.13 
Q9JKB1 
Ubiquitin carboxyl-terminal 
hydrolase isozyme L3  UCHL3_MOUSE 13 0.13 
O09159 
Lysosomal alpha-
mannosidase  MA2B1_MOUSE 47 0.12 
O55135 
Eukaryotic translation 
initiation factor 6  IF6_MOUSE 10 0.12 
P12382 ATP-dependent 6- PFKAL_MOUSE 38 0.12 
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 phosphofructokinase, liver 
type  
P29533 
Vascular cell adhesion 
protein 1  VCAM1_MOUSE 39 0.12 
P31809 
Carcinoembryonic antigen-
related cell adhesion 
molecule 1  CEAM1_MOUSE 18 0.12 
P32921 
Tryptophan--tRNA ligase, 
cytoplasmic  SYWC_MOUSE 33 0.12 
P62918 60S ribosomal protein L8  RL8_MOUSE 14 0.12 
P97290 
Plasma protease C1 
inhibitor  IC1_MOUSE 25 0.12 
Q5SYD0 Unconventional myosin-Id  MYO1D_MOUSE 74 0.12 
Q61553 Fascin  FSCN1_MOUSE 29 0.12 
Q6IRU2 Tropomyosin alpha-4 chain  TPM4_MOUSE 20 0.12 
Q6PDM2 
Serine/arginine-rich splicing 
factor 1  SRSF1_MOUSE 15 0.12 
Q91ZJ5 
UTP--glucose-1-phosphate 
uridylyltransferase  UGPA_MOUSE 30 0.12 
Q99KC8 
von Willebrand factor A 
domain-containing protein 
5A  VMA5A_MOUSE 45 0.12 
Q99KP6 
Pre-mRNA-processing 
factor 19  PRP19_MOUSE 19 0.12 
Q99KQ4 
Nicotinamide 
phosphoribosyltransferase  NAMPT_MOUSE 29 0.12 
Q99LF4 
tRNA-splicing ligase RtcB 
homolog  RTCB_MOUSE 29 0.12 
Q9CPY7 Cytosol aminopeptidase  AMPL_MOUSE 32 0.12 
Q9CZD3 Glycine--tRNA ligase  SYG_MOUSE 50 0.12 
Q9D0K2 
Succinyl-CoA:3-ketoacid 
coenzyme A transferase 1, 
mitochondrial  SCOT1_MOUSE 25 0.12 
Q9D6J6 
NADH dehydrogenase 
[ubiquinone] flavoprotein 2, 
mitochondrial  NDUV2_MOUSE 16 0.12 
Q9D701 Uroplakin-3b-like protein  UPK3L_MOUSE 10 0.12 
Q9DBJ3 
Brain-specific angiogenesis 
inhibitor 1-associated 
protein 2-like protein 1  BI2L1_MOUSE 38 0.12 
Q9DCM0 
Persulfide dioxygenase 
ETHE1, mitochondrial  ETHE1_MOUSE 17 0.12 
Q9WUM3 Coronin-1B  COR1B_MOUSE 22 0.12 
G3X9C2 F-box only protein 50  FBX50_MOUSE 18 0.11 
O09117 
Synaptophysin-like protein 
1  SYPL1_MOUSE 10 0.11 
O35658 
Complement component 1 
Q subcomponent-binding 
protein, mitochondrial  C1QBP_MOUSE 14 0.11 
P17918 
Proliferating cell nuclear 
antigen  PCNA_MOUSE 18 0.11 
P32020 
Non-specific lipid-transfer 
protein  NLTP_MOUSE 30 0.11 
P40237 CD82 antigen  CD82_MOUSE 11 0.11 
P97822 
Acidic leucine-rich nuclear 
phosphoprotein 32 family AN32E_MOUSE 10 0.11 
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 member E  
Q04736 
Tyrosine-protein kinase 
Yes  YES_MOUSE 28 0.11 
Q0P557 Mitochondria-eating protein  MIEAP_MOUSE 29 0.11 
Q3TEA8 
Heterochromatin protein 1-
binding protein 3  HP1B3_MOUSE 33 0.11 
Q3U1J4 
DNA damage-binding 
protein 1  DDB1_MOUSE 53 0.11 
Q60864 
Stress-induced-
phosphoprotein 1  STIP1_MOUSE 41 0.11 
Q61792 
LIM and SH3 domain 
protein 1  LASP1_MOUSE 16 0.11 
Q8BFR4 
N-acetylglucosamine-6-
sulfatase  GNS_MOUSE 28 0.11 
Q8BL97 
Serine/arginine-rich splicing 
factor 7  SRSF7_MOUSE 17 0.11 
Q8JZQ9 
Eukaryotic translation 
initiation factor 3 subunit B  EIF3B_MOUSE 39 0.11 
Q8K2I3 
Dimethylaniline 
monooxygenase [N-oxide-
forming] 2  FMO2_MOUSE 30 0.11 
Q9CR68 
Cytochrome b-c1 complex 
subunit Rieske, 
mitochondrial  UCRI_MOUSE 16 0.11 
Q9D0F9 Phosphoglucomutase-1  PGM1_MOUSE 37 0.11 
Q9DBF1 
Alpha-aminoadipic 
semialdehyde 
dehydrogenase  AL7A1_MOUSE 24 0.11 
Q9QZ06 Toll-interacting protein  TOLIP_MOUSE 14 0.11 
Q9QZF2 Glypican-1  GPC1_MOUSE 33 0.11 
Q9WVK4 
EH domain-containing 
protein 1  EHD1_MOUSE 33 0.11 
Q9Z2C6 Uroplakin-1b  UPK1B_MOUSE 12 0.11 
O35295 
Transcriptional activator 
protein Pur-beta  PURB_MOUSE 16 0.1 
O55029 Coatomer subunit beta~  COPB2_MOUSE 49 0.1 
Q11011 
Puromycin-sensitive 
aminopeptidase  PSA_MOUSE 53 0.1 
Q61490 CD166 antigen  CD166_MOUSE 29 0.1 
Q61699 
Heat shock protein 105 
kDa  HS105_MOUSE 54 0.1 
Q64704 Syntaxin-3  STX3_MOUSE 14 0.1 
Q7TSV4 Phosphoglucomutase-2  PGM2_MOUSE 36 0.1 
Q8BJZ3 Protein lifeguard 3  LFG3_MOUSE 6 0.1 
Q8CI51 
PDZ and LIM domain 
protein 5  PDLI5_MOUSE 33 0.1 
Q922Q4 
Pyrroline-5-carboxylate 
reductase 2  P5CR2_MOUSE 17 0.1 
Q99MN1 Lysine--tRNA ligase  SYK_MOUSE 30 0.1 
Q9CQA3 
Succinate dehydrogenase 
[ubiquinone] iron-sulfur 
subunit, mitochondrial  SDHB_MOUSE 24 0.1 
Q9CR62 
Mitochondrial 2-
oxoglutarate/malate carrier 
protein  M2OM_MOUSE 21 0.1 
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 Q9CY50 
Translocon-associated 
protein subunit alpha  SSRA_MOUSE 10 0.1 
Q9D0L7 
Armadillo repeat-containing 
protein 10  ARM10_MOUSE 13 0.1 
Q9D710 
Thioredoxin-related 
transmembrane protein 2  TMX2_MOUSE 18 0.1 
Q9D711 Pirin  PIR_MOUSE 19 0.1 
Q9D819 Inorganic pyrophosphatase  IPYR_MOUSE 20 0.1 
Q9EP69 
Phosphatidylinositide 
phosphatase SAC1  SAC1_MOUSE 35 0.1 
Q9EQ06 
Estradiol 17-beta-
dehydrogenase 11  DHB11_MOUSE 17 0.1 
A2ASQ1 Agrin  AGRIN_MOUSE 89 0.09 
O08677 Kininogen-1  KNG1_MOUSE 30 0.09 
O35887 Calumenin  CALU_MOUSE 17 0.09 
O70133 
ATP-dependent RNA 
helicase A  DHX9_MOUSE 75 0.09 
O70400 
PDZ and LIM domain 
protein 1  PDLI1_MOUSE 19 0.09 
P10518 
Delta-aminolevulinic acid 
dehydratase  HEM2_MOUSE 15 0.09 
P26516 
26S proteasome non-
ATPase regulatory subunit 
7  PSMD7_MOUSE 15 0.09 
P45377 
Aldose reductase-related 
protein 2  ALD2_MOUSE 20 0.09 
Q61768 Kinesin-1 heavy chain  KINH_MOUSE 64 0.09 
Q64191 
N(4)-(beta-N-
acetylglucosaminyl)-L-
asparaginase  ASPG_MOUSE 17 0.09 
Q6ZWX6 
Eukaryotic translation 
initiation factor 2 subunit 1  IF2A_MOUSE 22 0.09 
Q8BH59 
Calcium-binding 
mitochondrial carrier 
protein Aralar1  CMC1_MOUSE 38 0.09 
Q8BK64 
Activator of 90 kDa heat 
shock protein ATPase 
homolog 1  AHSA1_MOUSE 24 0.09 
Q8CCH2 
NHL repeat-containing 
protein 3  NHLC3_MOUSE 20 0.09 
Q8K297 
Procollagen 
galactosyltransferase 1  GT251_MOUSE 40 0.09 
Q8VCT3 Aminopeptidase B  AMPB_MOUSE 33 0.09 
Q91V61 Sideroflexin-3  SFXN3_MOUSE 20 0.09 
Q922P8 
Transmembrane protein 
132A  T132A_MOUSE 44 0.09 
Q922Q8 
Leucine-rich repeat-
containing protein 59  LRC59_MOUSE 18 0.09 
Q99JB2 
Stomatin-like protein 2, 
mitochondrial  STML2_MOUSE 20 0.09 
Q99KP3 Lambda-crystallin homolog  CRYL1_MOUSE 20 0.09 
Q99L45 
Eukaryotic translation 
initiation factor 2 subunit 2  IF2B_MOUSE 22 0.09 
Q9CQ62 
2,4-dienoyl-CoA reductase, 
mitochondrial  DECR_MOUSE 23 0.09 
Q9CS42 Ribose-phosphate PRPS2_MOUSE 19 0.09 
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 pyrophosphokinase 2  
Q9D0I9 
Arginine--tRNA ligase, 
cytoplasmic  SYRC_MOUSE 42 0.09 
Q9D0M3 
Cytochrome c1, heme 
protein, mitochondrial  CY1_MOUSE 16 0.09 
Q9D136 
2-oxoglutarate and iron-
dependent oxygenase 
domain-containing protein 
3  OGFD3_MOUSE 17 0.09 
Q9D1P4 
Cysteine and histidine-rich 
domain-containing protein 
1  CHRD1_MOUSE 23 0.09 
A1A547 
Peptidoglycan recognition 
protein 3  PGRP3_MOUSE 19 0.08 
O08529 Calpain-2 catalytic subunit  CAN2_MOUSE 38 0.08 
O08911 
Mitogen-activated protein 
kinase 12  MK12_MOUSE 23 0.08 
O54984 ATPase Asna1  ASNA_MOUSE 15 0.08 
P01901 
H-2 class I 
histocompatibility antigen, 
K-B alpha chain  HA1B_MOUSE 19 0.08 
P30677 
Guanine nucleotide-binding 
protein subunit alpha-14  GNA14_MOUSE 24 0.08 
P31938 
Dual specificity mitogen-
activated protein kinase 
kinase 1  MP2K1_MOUSE 18 0.08 
P51863 
V-type proton ATPase 
subunit d 1  VA0D1_MOUSE 17 0.08 
Q00PI9 
Heterogeneous nuclear 
ribonucleoprotein U-like 
protein 2  HNRL2_MOUSE 41 0.08 
Q04447 Creatine kinase B-type  KCRB_MOUSE 21 0.08 
Q3UMR5 
Calcium uniporter protein, 
mitochondrial  MCU_MOUSE 17 0.08 
Q62087 
Serum 
paraoxonase/lactonase 3  PON3_MOUSE 17 0.08 
Q8BYM7 
Radial spoke head protein 
4 homolog A  RSH4A_MOUSE 27 0.08 
Q8K0C9 
GDP-mannose 4,6 
dehydratase  GMDS_MOUSE 30 0.08 
Q8R1F1 Niban-like protein 1  NIBL1_MOUSE 44 0.08 
Q8R5C5 Beta-centractin  ACTY_MOUSE 23 0.08 
Q91VM5 
RNA binding motif protein, 
X-linked-like-1  RMXL1_MOUSE 33 0.08 
Q99KV1 
DnaJ homolog subfamily B 
member 11  DJB11_MOUSE 21 0.08 
Q99LC3 
NADH dehydrogenase 
[ubiquinone] 1 alpha 
subcomplex subunit 10, 
mitochondrial  NDUAA_MOUSE 23 0.08 
Q9CXY6 
Interleukin enhancer-
binding factor 2  ILF2_MOUSE 21 0.08 
Q9D662 
Protein transport protein 
Sec23B  SC23B_MOUSE 39 0.08 
Q9D8V0 
Minor histocompatibility 
antigen H13  HM13_MOUSE 15 0.08 
Q9DC69 NADH dehydrogenase NDUA9_MOUSE 27 0.08 
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 [ubiquinone] 1 alpha 
subcomplex subunit 9, 
mitochondrial  
Q9ERH8 
Solute carrier family 28 
member 3  S28A3_MOUSE 28 0.08 
Q9JK81 
UPF0160 protein MYG1, 
mitochondrial  MYG1_MOUSE 27 0.08 
Q9WVJ2 
26S proteasome non-
ATPase regulatory subunit 
13  PSD13_MOUSE 26 0.08 
O08917 Flotillin-1  FLOT1_MOUSE 31 0.07 
O88632 Semaphorin-3F  SEM3F_MOUSE 51 0.07 
O88968 Transcobalamin-2  TCO2_MOUSE 23 0.07 
P06909 Complement factor H  CFAH_MOUSE 69 0.07 
P09055 Integrin beta-1  ITB1_MOUSE 39 0.07 
P12367 
cAMP-dependent protein 
kinase type II-alpha 
regulatory subunit  KAP2_MOUSE 21 0.07 
P19324 Serpin H1  SERPH_MOUSE 25 0.07 
P37889 Fibulin-2  FBLN2_MOUSE 50 0.07 
P46664 
Adenylosuccinate 
synthetase isozyme 2  PURA2_MOUSE 27 0.07 
P48722 
Heat shock 70 kDa protein 
4L  HS74L_MOUSE 60 0.07 
P63005 
Platelet-activating factor 
acetylhydrolase IB subunit 
alpha  LIS1_MOUSE 27 0.07 
P63037 
DnaJ homolog subfamily A 
member 1  DNJA1_MOUSE 22 0.07 
P70168 Importin subunit beta-1  IMB1_MOUSE 38 0.07 
P81117 Nucleobindin-2  NUCB2_MOUSE 24 0.07 
P84091 AP-2 complex subunit mu  AP2M1_MOUSE 29 0.07 
Q04998 Inhibin beta A chain  INHBA_MOUSE 30 0.07 
Q08509 
Epidermal growth factor 
receptor kinase substrate 8  EPS8_MOUSE 45 0.07 
Q3THS6 
S-adenosylmethionine 
synthase isoform type-2  METK2_MOUSE 21 0.07 
Q60737 
Casein kinase II subunit 
alpha  CSK21_MOUSE 21 0.07 
Q60749 
KH domain-containing, 
RNA-binding, signal 
transduction-associated 
protein 1  KHDR1_MOUSE 22 0.07 
Q60972 
Histone-binding protein 
RBBP4  RBBP4_MOUSE 15 0.07 
Q61092 Laminin subunit gamma-2  LAMC2_MOUSE 69 0.07 
Q6ZQ38 
Cullin-associated NEDD8-
dissociated protein 1  CAND1_MOUSE 66 0.07 
Q80YQ8 Protein RMD5 homolog A  RMD5A_MOUSE 26 0.07 
Q8BGX1 
PC-esterase domain-
containing protein 1B  PED1B_MOUSE 22 0.07 
Q8BWN8 
Acyl-coenzyme A 
thioesterase 4  ACOT4_MOUSE 21 0.07 
Q8QZT1 
Acetyl-CoA 
acetyltransferase, THIL_MOUSE 23 0.07 
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 mitochondrial  
Q8VE37 
Regulator of chromosome 
condensation  RCC1_MOUSE 18 0.07 
Q9CY58 
Plasminogen activator 
inhibitor 1 RNA-binding 
protein  PAIRB_MOUSE 23 0.07 
Q9ER72 
Cysteine--tRNA ligase, 
cytoplasmic  SYCC_MOUSE 51 0.07 
Q9WVP1 AP-1 complex subunit mu-2  AP1M2_MOUSE 28 0.07 
Q9Z2W1 
Serine/threonine-protein 
kinase 25  STK25_MOUSE 23 0.07 
O08528 Hexokinase-2  HXK2_MOUSE 55 0.06 
O08810 
116 kDa U5 small nuclear 
ribonucleoprotein 
component  U5S1_MOUSE 56 0.06 
O35114 
Lysosome membrane 
protein 2  SCRB2_MOUSE 24 0.06 
P26369 
Splicing factor U2AF 65 
kDa subunit  U2AF2_MOUSE 19 0.06 
P26638 
Serine--tRNA ligase, 
cytoplasmic  SYSC_MOUSE 29 0.06 
P30999 Catenin delta-1  CTND1_MOUSE 55 0.06 
P50431 
Serine 
hydroxymethyltransferase, 
cytosolic  GLYC_MOUSE 28 0.06 
P97855 
Ras GTPase-activating 
protein-binding protein 1  G3BP1_MOUSE 25 0.06 
P98063 
Bone morphogenetic 
protein 1  BMP1_MOUSE 58 0.06 
Q0MW30 
E3 ubiquitin-protein ligase 
NEURL1B  NEU1B_MOUSE 23 0.06 
Q0VBK2 
Keratin, type II cytoskeletal 
80  K2C80_MOUSE 33 0.06 
Q32NZ6 
Transmembrane channel-
like protein 5  TMC5_MOUSE 42 0.06 
Q3TJD7 
PDZ and LIM domain 
protein 7  PDLI7_MOUSE 28 0.06 
Q5XJY5 Coatomer subunit delta  COPD_MOUSE 29 0.06 
Q61235 Beta-2-syntrophin  SNTB2_MOUSE 30 0.06 
Q61655 
ATP-dependent RNA 
helicase DDX19A  DD19A_MOUSE 34 0.06 
Q68FL6 
Methionine--tRNA ligase, 
cytoplasmic  SYMC_MOUSE 49 0.06 
Q6P9R2 
Serine/threonine-protein 
kinase OSR1  OXSR1_MOUSE 27 0.06 
Q7TT45 
Ras-related GTP-binding 
protein D  RRAGD_MOUSE 23 0.06 
Q8BG22 
Calcium-activated chloride 
channel regulator 2  CLCA2_MOUSE 45 0.06 
Q8BGH2 
Sorting and assembly 
machinery component 50 
homolog  SAM50_MOUSE 29 0.06 
Q8BGQ7 
Alanine--tRNA ligase, 
cytoplasmic  SYAC_MOUSE 56 0.06 
Q8BVE3 
V-type proton ATPase 
subunit H  VATH_MOUSE 27 0.06 
Q8BXZ1 Protein disulfide-isomerase TMX3_MOUSE 25 0.06 
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 TMX3  
Q8C522 
Endonuclease domain-
containing 1 protein  ENDD1_MOUSE 23 0.06 
Q8CGC7 
Bifunctional 
glutamate/proline--tRNA 
ligase  SYEP_MOUSE 94 0.06 
Q8CGK3 
Lon protease homolog, 
mitochondrial  LONM_MOUSE 52 0.06 
Q8K0E7 Serine incorporator 2  SERC2_MOUSE 12 0.06 
Q91YT0 
NADH dehydrogenase 
[ubiquinone] flavoprotein 1, 
mitochondrial  NDUV1_MOUSE 27 0.06 
Q99LD4 
COP9 signalosome 
complex subunit 1  CSN1_MOUSE 26 0.06 
Q9CWK8 Sorting nexin-2  SNX2_MOUSE 30 0.06 
Q9D1A2 
Cytosolic non-specific 
dipeptidase  CNDP2_MOUSE 26 0.06 
Q9DBE0 
Cysteine sulfinic acid 
decarboxylase  CSAD_MOUSE 31 0.06 
Q9DBG3 AP-2 complex subunit beta  AP2B1_MOUSE 47 0.06 
Q9DBX6 Cytochrome P450 2S1  CP2S1_MOUSE 28 0.06 
Q9ES97 Reticulon-3  RTN3_MOUSE 45 0.06 
Q9JHU4 
Cytoplasmic dynein 1 
heavy chain 1  DYHC1_MOUSE 283 0.06 
Q9JIF7 Coatomer subunit beta  COPB_MOUSE 56 0.06 
Q9JIX9 
Fas-activated 
serine/threonine kinase  FASTK_MOUSE 30 0.06 
Q9JLJ2 
4-
trimethylaminobutyraldehyd
e dehydrogenase  AL9A1_MOUSE 27 0.06 
Q9JLR1 
Protein transport protein 
Sec61 subunit alpha 
isoform 2  S61A2_MOUSE 17 0.06 
Q9WUM4 Coronin-1C  COR1C_MOUSE 24 0.06 
O08914 
Fatty-acid amide hydrolase 
1  FAAH1_MOUSE 26 0.05 
O70194 
Eukaryotic translation 
initiation factor 3 subunit D  EIF3D_MOUSE 27 0.05 
O89023 Tripeptidyl-peptidase 1  TPP1_MOUSE 22 0.05 
P29416 
Beta-hexosaminidase 
subunit alpha  HEXA_MOUSE 25 0.05 
P48453 
Serine/threonine-protein 
phosphatase 2B catalytic 
subunit beta isoform  PP2BB_MOUSE 27 0.05 
P50544 
Very long-chain specific 
acyl-CoA dehydrogenase, 
mitochondrial  ACADV_MOUSE 43 0.05 
P51655 Glypican-4  GPC4_MOUSE 29 0.05 
P97427 
Dihydropyrimidinase-
related protein 1  DPYL1_MOUSE 33 0.05 
Q3U9G9 Lamin-B receptor  LBR_MOUSE 29 0.05 
Q60598 Src substrate cortactin  SRC8_MOUSE 28 0.05 
Q60715 
Prolyl 4-hydroxylase 
subunit alpha-1  P4HA1_MOUSE 29 0.05 
Q61545 RNA-binding protein EWS  EWS_MOUSE 23 0.05 
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 Q64133 
Amine oxidase [flavin-
containing] A  AOFA_MOUSE 30 0.05 
Q64455 
Receptor-type tyrosine-
protein phosphatase eta  PTPRJ_MOUSE 54 0.05 
Q6DFW4 Nucleolar protein 58  NOP58_MOUSE 27 0.05 
Q6PDK8 
E3 ubiquitin-protein ligase 
DTX4  DTX4_MOUSE 32 0.05 
Q80UG5 Septin-9  SEPT9_MOUSE 40 0.05 
Q8BH04 
Phosphoenolpyruvate 
carboxykinase [GTP], 
mitochondrial  PCKGM_MOUSE 35 0.05 
Q8BU30 
Isoleucine--tRNA ligase, 
cytoplasmic  SYIC_MOUSE 67 0.05 
Q8CHT0 
Delta-1-pyrroline-5-
carboxylate 
dehydrogenase, 
mitochondrial  AL4A1_MOUSE 32 0.05 
Q8CIE6 Coatomer subunit alpha  COPA_MOUSE 76 0.05 
Q8R0X7 
Sphingosine-1-phosphate 
lyase 1  SGPL1_MOUSE 30 0.05 
Q8VCM8 Nicalin  NCLN_MOUSE 22 0.05 
Q91V92 ATP-citrate synthase  ACLY_MOUSE 61 0.05 
Q91WG0 Acylcarnitine hydrolase  EST2C_MOUSE 17 0.05 
Q99KG5 
Lipolysis-stimulated 
lipoprotein receptor  LSR_MOUSE 26 0.05 
Q9D6Z1 Nucleolar protein 56  NOP56_MOUSE 36 0.05 
Q9DBG7 
Signal recognition particle 
receptor subunit alpha  SRPR_MOUSE 41 0.05 
Q9ET30 
Transmembrane 9 
superfamily member 3  TM9S3_MOUSE 21 0.05 
Q9R069 
Basal cell adhesion 
molecule  BCAM_MOUSE 35 0.05 
E9Q557 Desmoplakin  DESP_MOUSE 207 0.04 
O35350 Calpain-1 catalytic subunit  CAN1_MOUSE 45 0.04 
P19096 Fatty acid synthase  FAS_MOUSE 131 0.04 
P23116 
Eukaryotic translation 
initiation factor 3 subunit A  EIF3A_MOUSE 90 0.04 
P23780 Beta-galactosidase  BGAL_MOUSE 28 0.04 
P41216 
Long-chain-fatty-acid--CoA 
ligase 1  ACSL1_MOUSE 39 0.04 
P70670 
Nascent polypeptide-
associated complex subunit 
alpha, muscle-specific form  NACAM_MOUSE 102 0.04 
P82198 
Transforming growth factor-
beta-induced protein ig-h3  BGH3_MOUSE 42 0.04 
Q3UPP8 
Centrosomal protein of 63 
kDa  CEP63_MOUSE 40 0.04 
Q3UQ44 
Ras GTPase-activating-like 
protein IQGAP2  IQGA2_MOUSE 96 0.04 
Q62318 
Transcription intermediary 
factor 1-beta  TIF1B_MOUSE 33 0.04 
Q80VA0 
N-
acetylgalactosaminyltransfe
rase 7  GALT7_MOUSE 45 0.04 
Q8C1A5 Thimet oligopeptidase  THOP1_MOUSE 45 0.04 
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 Q8CG14 
Complement C1s-A 
subcomponent  CS1A_MOUSE 28 0.04 
Q8JZQ2 AFG3-like protein 2  AFG32_MOUSE 53 0.04 
Q8JZR0 
Long-chain-fatty-acid--CoA 
ligase 5  ACSL5_MOUSE 37 0.04 
Q8K0D5 
Elongation factor G, 
mitochondrial  EFGM_MOUSE 45 0.04 
Q8R146 
Acylamino-acid-releasing 
enzyme  APEH_MOUSE 36 0.04 
Q91VA1 
Choline transporter-like 
protein 4  CTL4_MOUSE 27 0.04 
Q91VD9 
NADH-ubiquinone 
oxidoreductase 75 kDa 
subunit, mitochondrial  NDUS1_MOUSE 42 0.04 
Q91W50 
Cold shock domain-
containing protein E1  CSDE1_MOUSE 55 0.04 
Q99MD9 
Nuclear autoantigenic 
sperm protein  NASP_MOUSE 43 0.04 
Q9D0R2 
Threonine--tRNA ligase, 
cytoplasmic  SYTC_MOUSE 47 0.04 
Q9D2R0 
Acetoacetyl-CoA 
synthetase  AACS_MOUSE 38 0.04 
Q9ES07 
Solute carrier family 15 
member 2  S15A2_MOUSE 29 0.04 
Q9JHE3 Neutral ceramidase  ASAH2_MOUSE 25 0.04 
Q9QXX4 
Calcium-binding 
mitochondrial carrier 
protein Aralar2  CMC2_MOUSE 37 0.04 
Q9QYB5 Gamma-adducin  ADDG_MOUSE 31 0.04 
Q9R0E2 
Procollagen-lysine,2-
oxoglutarate 5-dioxygenase 
1  PLOD1_MOUSE 43 0.04 
Q9WTR5 Cadherin-13  CAD13_MOUSE 33 0.04 
Q9Z110 
Delta-1-pyrroline-5-
carboxylate synthase  P5CS_MOUSE 48 0.04 
Q9Z185 
Protein-arginine deiminase 
type-1  PADI1_MOUSE 36 0.04 
Q9Z2I0 
LETM1 and EF-hand 
domain-containing protein 
1, mitochondrial  LETM1_MOUSE 45 0.04 
B0V2N1 
Receptor-type tyrosine-
protein phosphatase S  PTPRS_MOUSE 96 0.03 
E9Q5G3 Kinesin-like protein KIF23  KIF23_MOUSE 53 0.03 
P17426 
AP-2 complex subunit 
alpha-1  AP2A1_MOUSE 60 0.03 
P39054 Dynamin-2  DYN2_MOUSE 56 0.03 
P43406 Integrin alpha-V  ITAV_MOUSE 61 0.03 
P56399 
Ubiquitin carboxyl-terminal 
hydrolase 5  UBP5_MOUSE 43 0.03 
P56677 
Suppressor of 
tumorigenicity 14 protein 
homolog  ST14_MOUSE 36 0.03 
Q07139 Protein ECT2  ECT2_MOUSE 53 0.03 
Q3TDQ1 
Dolichyl-
diphosphooligosaccharide--
protein glycosyltransferase 
subunit STT3B  STT3B_MOUSE 35 0.03 
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 Q60997 
Deleted in malignant brain 
tumors 1 protein  DMBT1_MOUSE 55 0.03 
Q61739 Integrin alpha-6  ITA6_MOUSE 62 0.03 
Q6P5F9 Exportin-1  XPO1_MOUSE 58 0.03 
Q78PY7 
Staphylococcal nuclease 
domain-containing protein 
1  SND1_MOUSE 58 0.03 
Q8BFY9 Transportin-1  TNPO1_MOUSE 38 0.03 
Q8BIJ6 
Isoleucine--tRNA ligase, 
mitochondrial  SYIM_MOUSE 49 0.03 
Q8CDG1 Piwi-like protein 2  PIWL2_MOUSE 66 0.03 
Q8CFI0 
E3 ubiquitin-protein ligase 
NEDD4-like  NED4L_MOUSE 54 0.03 
Q8K310 Matrin-3  MATR3_MOUSE 46 0.03 
Q8VDM6 
Heterogeneous nuclear 
ribonucleoprotein U-like 
protein 1  HNRL1_MOUSE 45 0.03 
Q99MR6 
Serrate RNA effector 
molecule homolog  SRRT_MOUSE 49 0.03 
Q99P72 Reticulon-4  RTN4_MOUSE 45 0.03 
Q9EPL2 Calsyntenin-1  CSTN1_MOUSE 41 0.03 
Q9EQH2 
Endoplasmic reticulum 
aminopeptidase 1  ERAP1_MOUSE 52 0.03 
Q9JIK5 Nucleolar RNA helicase 2  DDX21_MOUSE 52 0.03 
Q9Z1T1 
AP-3 complex subunit beta-
1  AP3B1_MOUSE 64 0.03 
A2A8L5 
Receptor-type tyrosine-
protein phosphatase F  PTPRF_MOUSE 105 0.02 
B2RXS4 Plexin-B2  PLXB2_MOUSE 97 0.02 
G5E829 
Plasma membrane 
calcium-transporting 
ATPase 1  AT2B1_MOUSE 65 0.02 
P02468 Laminin subunit gamma-1  LAMC1_MOUSE 83 0.02 
P11087 Collagen alpha-1(I) chain  CO1A1_MOUSE 82 0.02 
P59509 
A disintegrin and 
metalloproteinase with 
thrombospondin motifs 19  ATS19_MOUSE 63 0.02 
Q05793 
Basement membrane-
specific heparan sulfate 
proteoglycan core protein  PGBM_MOUSE 151 0.02 
Q3UPL0 
Protein transport protein 
Sec31A  SC31A_MOUSE 53 0.02 
Q3UTJ2 
Sorbin and SH3 domain-
containing protein 2  SRBS2_MOUSE 70 0.02 
Q5ND34 
WD repeat-containing 
protein 81  WDR81_MOUSE 91 0.02 
Q61001 Laminin subunit alpha-5  LAMA5_MOUSE 158 0.02 
Q61595 Kinectin  KTN1_MOUSE 90 0.02 
Q62315 Protein Jumonji  JARD2_MOUSE 68 0.02 
Q64511 DNA topoisomerase 2-beta  TOP2B_MOUSE 100 0.02 
Q68FD7 
Folliculin-interacting protein 
1  FNIP1_MOUSE 68 0.02 
Q6F3F9 
G-protein coupled receptor 
126  GP126_MOUSE 45 0.02 
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 Q6P5E4 
UDP-glucose:glycoprotein 
glucosyltransferase 1  UGGG1_MOUSE 84 0.02 
Q6VH22 
Intraflagellar transport 
protein 172 homolog  IF172_MOUSE 116 0.02 
Q7TPV4 Myb-binding protein 1A  MBB1A_MOUSE 78 0.02 
Q80XI3 
Eukaryotic translation 
initiation factor 4 gamma 3  IF4G3_MOUSE 97 0.02 
Q8BMJ2 
Leucine--tRNA ligase, 
cytoplasmic  SYLC_MOUSE 61 0.02 
Q921M3 Splicing factor 3B subunit 3  SF3B3_MOUSE 60 0.02 
Q9QXS1 Plectin  PLEC_MOUSE 342 0.02 
Q07113 
Cation-independent 
mannose-6-phosphate 
receptor  MPRI_MOUSE 124 0.01 
Q61789 Laminin subunit alpha-3  LAMA3_MOUSE 181 0.01 
Q6P4T2 
U5 small nuclear 
ribonucleoprotein 200 kDa 
helicase  U520_MOUSE 122 0.01 
Q8C6K9 Collagen alpha-6(VI) chain  CO6A6_MOUSE 127 0.01 
Q8R0W0 Epiplakin  EPIPL_MOUSE 388 0.01 
Q99PV0 
Pre-mRNA-processing-
splicing factor 8  PRP8_MOUSE 145 0.01 
Q9D952 Envoplakin  EVPL_MOUSE 126 0.01 
Q9QZZ4 Unconventional myosin-XV  MYO15_MOUSE 188 0.01 
A2AAJ9 Obscurin  OBSCN_MOUSE 495 0 
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 Table S2: Antibodies used for immuno-detection studies 
Primary Antibody 
 
Type 
 
Manufacturer 
 
Anti- Bpifa1 Rabbit polyclonal 
 
Prepared in lab (Musa et al 2012) 
 
Anti- FoxJ1 Mouse monoclonal Affymetrix eBioscience (2A5 Cat no 14-9965) 
Anti- Muc5B Rabbit polyclonal Santa Cruz Biotechnology (H-300, Sc-20119) 
Anti- P63 Mouse monoclonal 
Santa Cruz Biotechnology (4A4, Cat no Sc-
8431) 
Anti- Lactotransferrin Rabbit antisera Milipore (Cat no 07- 685) 
Anti- Reg3γ Rabbit polyclonal 
Kindly provided by Professor Lora Hooper 
(Cash et al 2006) 
Anti- Zo1 Rabbit polyclonal Life Technologies (Cat no 40-2200) 
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Table S3: Primer sequences and amplicon sizes for end point reverse 
transcription PCR 
Assay Primer type Sequence (5’-3’) Product 
size (bp) 
Bpifa1 
Forward 
Reverse 
ACAGAGGAGCCGACGTCTAA 
CCAAGAAAGCTGAAGGTTC 
127 
Tekt1 
Forward 
Reverse 
CAGTGCGAAGTGGTAGACG 
TTCACCTGGATTTCCTCCTG 
373 
Muc5B 
Forward 
Reverse 
ATGGTGACCAAGAGCCAAAA 
CAGGACTGTTCACCCAGGTT 
178 
Muc5AC 
Forward 
Reverse 
GCACCAAAGACAGCAGATCA 
CTGAGAGGTTTGCAGCTCCT 
167 
Lactotransferrin 
Forward 
Reverse 
TCTGTCCCTGTGTATTGGT 
GTTTCCGGGTGTCATCAAGG 
237 
SP-D 
Forward 
Reverse 
AAGCAGGGGAACATAGGACC 
GCCTTTTGCCCCTGTAGATC 
109 
Bpifb1 
Forward 
Reverse 
CCCTGACCAAGATCCTTGAA 
GAGGCTGGAGTGAGCTTGAG 
148 
Keratin 5 
Forward 
Reverse 
ACCTTCGAAACACCAAGCAC 
TGACTGGTCCAACTCCTTCC 
337 
Vimentin 
Forward 
Reverse 
CAAGCAGGAGTCAAACGAG 
CCTGTAGGTGGCGATCTCAA 
273 
Reg3ᵞ  
Forward 
Reverse 
CCTGTCCTCCATGATCAAAGC 
GCAGACATAGGGTAACTCTAAGT 
250 
Oaz1 
Forward 
Reverse 
ACAGAGGAGCCGACGTCTAA 
CCAAGAAAGCTGAAGGTTC 
274 
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